WO2014076696A1 - Percutaneously-deliverable mechanical valve - Google Patents
Percutaneously-deliverable mechanical valve Download PDFInfo
- Publication number
- WO2014076696A1 WO2014076696A1 PCT/IL2013/050937 IL2013050937W WO2014076696A1 WO 2014076696 A1 WO2014076696 A1 WO 2014076696A1 IL 2013050937 W IL2013050937 W IL 2013050937W WO 2014076696 A1 WO2014076696 A1 WO 2014076696A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- valve member
- valve
- lumen
- tubular element
- configuration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2403—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with pivoting rigid closure members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2469—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with resilient valve members, e.g. conical spiral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/2436—Deployment by retracting a sheath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0041—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using additional screws, bolts, dowels or rivets, e.g. connecting screws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/005—Rosette-shaped, e.g. star-shaped
Definitions
- Some applications of the present invention relate in general to valve replacement. More specifically, some applications of the present invention relate to prosthetic valves for replacement of a cardiac valve. BACKGROUND
- Ischemic heart disease causes regurgitation of a heart valve by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the valve annulus. Dilation of the annulus of the valve prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.
- a percutaneously-deliverable (e.g., transluminally-deliverable) mechanical prosthetic valve comprising a tubular element and a valve member.
- the tubular element and valve member are restrained in respective compressed configurations for delivery, and automatically expand into respective expanded configurations when released at the native valve.
- a tubular element shaped to define a lumen therethrough, and a valve member, configured to be coupled to the tubular element and to be disposed within the lumen, and
- the valve member is generally cylindrical, and the prosthetic valve is configured to be percutaneously delivered into the subject, and
- the lumen has an expanded width that is greater than the compressed width
- valve member is generally disc-shaped, is coupled to the tubular element, and is disposed within the lumen.
- the prosthetic valve is configured to function as a check valve when in the expanded configuration thereof, and not when in the compressed configuration thereof.
- the valve member in the compressed configuration, is coupled to the tubular element.
- the valve member in the compressed configuration, is disposed within the lumen.
- the lumen has a first end and a second end
- valve member when the valve is in the expanded configuration thereof:
- the valve member in the expanded configuration, is configured to move between the open and closed states in response to changes in relative pressure between the first and second ends of the lumen.
- the valve member in at least the closed state thereof, has a diameter that is no more than 20 percent smaller than the expanded width of the lumen.
- the valve member has a compressed diameter in the compressed configuration of the prosthetic valve, and an expanded diameter in the in the expanded configuration of the prosthetic valve, and the expanded diameter is at least twice as great as the compressed diameter.
- the prosthetic valve in the expanded configuration, is configured to act as a check valve.
- the valve member in the expanded configuration, is configured to move toward the open state when pressure at the first end of the lumen is greater than pressure at the second end of the lumen, and to move toward the closed state when pressure at the second end of the lumen is greater than pressure at the first end of the lumen.
- valve member is coupled to the tubular element at at least two coupling points, the coupling points defining an axis therebetween.
- valve member is configured to move between the open and closed states thereof, by rotating around the axis between the coupling points.
- valve member is configured to move between the open and closed states thereof, by deflecting around the axis between the coupling points.
- the apparatus further includes a coupling rod, coupled to the coupling points, and coupled to the valve member along the axis between the coupling points, and the valve member is configured to move between the open and closed states thereof, by bending around the coupling rod.
- the prosthetic valve includes a coupling element that includes at least one strut, the strut being coupled to the tubular element, and to the valve member at a coupling point that is generally midway across a diameter of the valve member, and the valve member is configured to move between the open and closed states by deflecting from the coupling point.
- valve member is configured to move between the open and closed states by collapsing and expanding.
- the valve member is configured to move between the open and closed states thereof without changing a shape thereof.
- the prosthetic valve is configured such that, when the valve member moves toward the open state, at least part of the valve member moves toward the first end of the lumen and at least part of the valve member moves toward the second end of the lumen.
- the valve member is configured to move between the open and closed states thereof by changing a shape thereof.
- valve member is configured to be biased toward being in the closed state thereof.
- the prosthetic valve in the compressed configuration, has a greatest transverse diameter of less than 12 mm.
- the prosthetic valve in the compressed configuration, has a greatest transverse diameter of less than 9 mm.
- the prosthetic valve in the compressed configuration, has a greatest transverse diameter of less than 6 mm. In an application, the prosthetic valve is intracorporeally expandable from the compressed configuration to the expanded configuration.
- the prosthetic valve is configured to be percutaneously delivered in the constrained configuration thereof, by being restrained in the compressed configuration during the percutaneous delivery, and the prosthetic valve is configured to automatically expand toward the expanded configuration thereof when no longer restrained.
- FIGs. 1A-D are schematic illustrations of a prosthetic valve, comprising a tubular element and a valve member, in accordance with some applications of the invention
- FIGs. 2A-B are schematic illustrations of the valve member, in accordance with respective applications of the invention.
- Figs. 3A-B are schematic illustrations of a prosthetic valve in open and closed states thereof, in accordance with some applications of the invention
- Figs. 4A-C are schematic illustrations of a prosthetic valve, comprising a tubular element and a valve member, in accordance with some applications of the invention.
- Figs. 5A-C are schematic illustrations of a prosthetic valve comprising a tubular element and a valve member, in accordance with some applications of the invention.
- Figs. 1A-D are schematic illustrations of a prosthetic valve 20, comprising a tubular element 22 and a valve member 24, in accordance with some applications of the invention.
- valve member is defined as the movable obstruction (e.g., inside the tubular element) that restricts and/or controls flow through the valve, as is known in the general valve art.
- Prosthetic valve 20 is configured to be placed in a lumen of the body of the subject, such as in a blood vessel and/or at a native valve of the subject.
- prosthetic valve 20 is configured to be placed at a native heart valve of a subject, and to replace native functionality of the native valve.
- Fig. 1A shows tubular element 22 alone
- Fig. IB shows valve member 24 alone
- Fig. 1C shows valve 20 in a compressed configuration thereof
- Fig. ID shows valve 20 in an expanded configuration thereof, in accordance with some applications of the invention.
- Fig. 1A shows tubular element 22, in an expanded configuration thereof, in accordance with some applications of the invention.
- Tubular element 22 is shaped to define a lumen 23 therethrough, and has a length dl along a longitudinal axis of the tubular element, from a first end of the lumen to a second end of the lumen (e.g., from a first end of element 22 to a second end of element 22).
- Lumen 23 is defined by an inner surface 36 (Fig. ID) of tubular element 22, and has a width d2. That is, d2 represents an inner width of tubular element 22.
- tubular element 22 is generally cylindrical (i.e., element 22 has a generally circular transverse cross- section), and width d2 represents a diameter of lumen 23.
- tubular element 22 has a transverse cross-section that is not generally circular, and width d2 represents a maximum width of lumen 23.
- tubular element 22 has length of greater than 10 mm and/or less than 30 mm, and an inner width of greater than 20 mm and/or less than 40 mm.
- tubular member 22 comprises a frame 26 that defines a circumferentially-repeating arrangement of cells 27.
- frame 26 defines, along length dl, longitudinal columns cl comprising one cell 27, alternating with longitudinal columns c2 comprising two cells.
- frame 26 defines circumferential rows comprising more than 10 and/or less than 25 cells 27 (e.g., 18 cells). It is to be noted, however, that the scope of the invention includes other configurations of frame 26.
- valve member 24 in an expanded configuration thereof, in accordance with some applications of the invention.
- Valve member 24 typically has a shape that is similar to that of lumen 23 of tubular element 22. That is, a transverse cross- section of valve member 24 typically has a shape that is similar to the shape of the transverse cross-section of lumen 23.
- valve member 24 typically has a generally disc-shaped transverse cross-section.
- other dimensions and/or shapes of valve member 24 may vary (e.g., as described with reference to Figs. 2A-B).
- valve member 24 has a width d4 that is no more than 20% smaller than width d2 of tubular element 22 (e.g., no more than 10% smaller, such as no more than 5% smaller).
- widths d3 and d4 represent transverse cross-sectional diameters of lumen 23 and valve member 24, respectively, and the diameter of valve member 24 is typically no less than 20% smaller than the diameter of lumen 23 (i.e., no less than 20% smaller than the inner diameter of tubular element 22).
- width d4 is typically greater than 20 mm and/or less than 40 mm (e.g., 20-40 mm, such as 30 mm).
- valve member 24 comprises a frame 28 that defines an outer edge 30, an inner edge 32, and a radially-repeating arrangement of cells 29, disposed between the inner and outer edges.
- Inner edge 32 defines an opening 42, the presence of which facilitates compression of valve member 24 into the compressed configuration thereof (e.g., as described with reference to Fig. 1C). That is, the absence of frame material at opening 42 facilitates compression of the valve member into a generally cylindrical shape.
- opening 42 has a width d5 (e.g., a diameter) of more than 5 mm and/or less than 20 mm (e.g., between 5 and 20 mm, such as 12 mm).
- frame 28 may comprise a portion of increased flexibility, e.g., instead of defining opening 42.
- Figs. 1A-B show frames 26 and 28 of tubular element 22 and valve member 24, respectively.
- tubular element 22 and valve member 24 comprise a covering 40, e.g., as shown in Figs. 1C-D.
- Covering 40 covers at least part of frames 26 and 28.
- the covering has a thickness that is less than 1 mm (e.g., between 0.05 mm and 0.6 mm).
- Fig. 1C shows valve 20 in the compressed configuration thereof, in which valve member 24, in a compressed configuration thereof, is disposed within lumen 23 of tubular element 22, in the compressed configuration thereof.
- Fig. ID shows valve 20 in the expanded configuration thereof, in which valve member 24, in an expanded configuration thereof, is disposed within lumen 23 of tubular element 22, in an expanded configuration thereof.
- Valve 20 is configured to be percutaneously (e.g., transcatheterally and/or transluminally, such as transfemorally) delivered to the native heart valve of a subject, by being compressed (e.g., "crimped") into the compressed configuration thereof (i.e., a delivery configuration thereof).
- Valve 20 is typically configured to be restrained in the compressed configuration (e.g., by an overtube) during delivery of the valve, and to automatically move into an expanded configuration when released (e.g., by being deployed from the overtube).
- frames 26 and 28 comprise a shape-memory material such as, but not limited to, nitinol, which facilitates this automatic expansion.
- Covering 40 typically covers inner surface 36 of cylindrical element 22 and at least one side of valve member 24, including opening 42. Opening 42 is thereby an opening in frame 28 but typically not an opening in covering 40, and thereby typically not an opening through the entire of valve member 24 (Fig. ID). As described hereinabove, tubular element 22 is typically generally cylindrical.
- element 22 is typically generally cylindrical in the expanded configuration thereof.
- Tubular element 22 is typically also generally cylindrical in the compressed configuration thereof.
- tubular element 22 e.g., lumen 23 thereof
- width d6 e.g., a diameter
- width d2 is more than 1.5 times (e.g., more than 4 times) greater than width d6.
- valve member 24 is typically generally disc-shaped. That is, member 24 is typically generally disc-shaped in the expanded configuration thereof.
- valve member 24 is typically elongate, such as generally cylindrical, and has a width (e.g., a diameter) d7.
- width d4 (Fig. IB) is more than twice (e.g., more than 5 times, such as more than 10 times) greater than width d7.
- first end 33 of the cylinder defined by valve member 24 in the compressed configuration expands to define outer edge 30 of the valve member in the expanded configuration
- second end 35 of the cylinder expands to define inner edge 32.
- covering 40 covers opening 42 in frame 28, and therefore inner edge 32 is an inner edge of frame 28, and does not define an opening through the entire of valve member 24.
- Valve member 24 is typically disposed in lumen 23 of tubular element 22, in both the compressed configuration and the expanded configuration of valve 20.
- Valve member 24 is coupled to tubular element 22 at one or more (e.g., two) coupling points 60.
- Coupling points 60 comprise a coupling element 61, which may comprise a hinge, a connector (e.g., a connecting wire or suture), or any other suitable coupling element.
- coupling element 61 comprises a hinge formed by a protrusion 59 of frame 28 protruding into a slot 57 defined by frame 26.
- valve 20 further comprises one or more valve seats 62, configured to facilitate sealing between tubular element 22 and valve member 24.
- width d6 is greater than 2 mm and/or less than 12 mm (e.g., 2-10 mm, such as 3-6 mm).
- width d7 is greater than 2 mm and/or less than 10 mm (e.g., 2-8 mm, such as 2-6 mm).
- valve member 24 is configured to be compressible such that width d7 is smaller than width d6 in a maximally-compressed configuration of cylindrical element 22, e.g., such that cylindrical element 22 is compressible to generally the same width in the presence or absence of valve member 24.
- prosthetic valve 20 is configured to be placed (i.e., implanted) at a native heart valve of a subject, and to replace native functionality of the native valve.
- Prosthetic valve 20 is configured to act as a one-way valve (e.g., a check valve). That is, prosthetic valve 20 is configured to generally allow blood to flow in a first direction through lumen 23 of tubular element 22, and to inhibit blood from flowing in a second direction through the lumen.
- prosthetic valve 20 resembles and/or is configured to act as a "tilting disc” valve, as is known in the valve art.
- Valve member 24, disposed in lumen 23 of tubular element 22, provides valve functionality by being configured to move between an open state and a closed state in response to changes in relative pressure between each end of the lumen of tubular element 22 (i.e., in response to changes in relative pressure between blood at each end of the lumen; e.g., as described hereinbelow with reference to Figs. 3A-B). Movement of valve member 24 between the open and closed states thereof, thereby moves prosthetic valve 20 between open and closed states thereof.
- Figs. 2A-B are schematic illustrations of valve member 24, in accordance with respective applications of the invention.
- valve member 24 is typically disc-shaped in the expanded configuration thereof.
- Fig. 2A shows valve member 24, comprising a disc-shaped valve member 24a in the expanded configuration thereof, in accordance with some applications of the invention.
- frame 28 and opening 42 of valve member 24 are typically covered in covering 40.
- valve member 24 has a shape that is different to a flat disc.
- Fig. 2B shows valve member 24, comprising a frustoconical valve member 24b in the expanded configuration thereof, in accordance with some applications of the invention.
- frame 28 of valve member 24b comprises a frame 28b, which is configured to assume a frustoconical shape.
- covering 40 of valve member 24b comprises a covering 40b, which is configured to facilitate the valve member assuming the frustoconical shape, e.g., by restricting full expansion of the frame.
- valve member 24b comprises frame 28 (i.e., the same frame as member 24a), and the assuming of the frustoconical shape of valve member 24b is facilitated mainly (e.g., solely) by covering 40b.
- Figs. 2A-B show non-limiting examples of possible shapes of valve member 24, and that the scope of the invention includes valve member 24 having other shapes.
- tubular element 22 is shown as being substantially cylindrical, the scope of the invention includes tubular element 22 having other shapes, e.g., so as to facilitate blood flow, so as to conform to the shape of the native valve, and/or so as to facilitate coupling to the native valve and/or to auxiliary apparatus, such as a prosthetic valve support, such as the prosthetic valve supports described in US 2012/0022640 to Gross et al., which is incorporated herein by reference.
- tubular element 22 may comprise and/or define flared ends, barbs, clips, or any other such features, e.g., as are known in the art.
- Figs. 3A-B are schematic illustrations of functioning of valve 20, in accordance with respective applications of the invention.
- Figs. 3A-B show valve member 24 as disc-shaped (e.g., as shown for valve member 24a, described with reference to Fig. 2A), but valve members of other shapes may be used, and typically function similarly, mutatis mutandis.
- Valve member 24 is coupled to tubular element 22 at one or more coupling points
- valve member 24 is coupled to tubular element 22 at two coupling points 60 (e.g., coupling points 60a and 60b), such that the valve member can rotate around an axis al between the two coupling points.
- valve member 24 does not change shape when moving between the open and closed states.
- Fig. 3A shows valve member 24 (and thereby valve 20) in the closed state thereof
- Fig. 3B shows valve member 24 (and thereby valve 20) in the open state thereof.
- coupling points 60a and 60b do not lie on a central transverse axis a2 of tubular element 22. That is, axis al is typically a non-diameter chord of a transverse cross-section of tubular element 22. Such a configuration typically facilitates the functioning of valve 20 as a tilting-disc valve, as is known in the art.
- Valve 20 is configured such that valve member 24 moves between the open state and the closed state in response to changes in relative fluid pressure between each end of lumen 23, and thereby valve 20 is configured to act as a one way valve (e.g., a check valve).
- a one way valve e.g., a check valve.
- a first end 64 of tubular element 22 is in fluid communication with a second end 66 of the tubular element.
- the closed state fluid communication between the two ends is reduced, compared to in the open state (e.g., the first and second ends are substantially not in fluid communication).
- valve member 24 when fluid pressure at a second end 66 of tubular member 22 is higher than fluid pressure at a first end 64 of the tubular member (e.g., when fluid "tries” to move from the second end to the first end), valve member 24 is in (e.g., moves into) the closed state, thereby inhibiting flow of the fluid from the second end to the first end.
- valve member 24 when fluid pressure at first end 64 is higher than fluid pressure at second end 66 (e.g., when fluid "tries” to move from the first end to the second end), valve member 24 moves into the open state, thereby facilitating flow of the fluid from the first end to the second end.
- valve 20 acts as a check-valve (e.g., a tilting-disc valve), first end 64 is an upstream end of the valve, and second end 66 is a downstream end of the valve. It is to be noted that, when the valve member moves toward the open state, part of valve member 24 moves toward first end 64 (i.e., upstream), and part of the valve member moves toward second end 66 (i.e., downstream).
- check-valve e.g., a tilting-disc valve
- first end 64 is an upstream end of the valve
- second end 66 is a downstream end of the valve.
- Valve member 24 is typically configured (e.g., dimensioned) such that, in the closed state, outer edge 30 (see Fig. IB) of the valve member is positioned closely to the inner surface of tubular element 22 (e.g., the valve member is in close contact with the inner surface of the tubular element).
- the diameter of valve member 24 is typically no more than 20% smaller than the width of the lumen of the tubular element.
- valve 20 further comprises at least one valve seat 62, configured to facilitate contact (e.g., sealing) between valve member 24 and tubular element 22.
- seat 62 comprises two arc-shaped seats 62a and 62b that are disposed on the inner surface of the tubular element, and form respective arcs whose endpoints are adjacent to coupling points 60a and 60b.
- seat 62a forms a major arc between coupling points 60a and 60b, disposed slightly closer than coupling points 60 to first end 64
- seat 62b forms a complementary minor arc, disposed slightly closer than coupling points 60 to second end 66.
- the seats protrude into lumen 23 of tubular element 22, so as to facilitate sealing between the tubular element and valve member 24.
- the seats comprise a sealing element, such as a sealing surface, to further facilitate such sealing.
- the seats and/or sealing elements comprise a fabric, a resin and/or a polymer and are configured to fold, crumple, contract, and/or compress when valve 20 is compressed into the compressed configuration thereof, and to unfold, uncrumple, expand, and/or uncompress into the configuration shown in Figs. 3A-B, when valve 20 is moved into the uncompressed configuration thereof.
- the seats may comprise a fabric, sutured to frame 26, and configured to crumple and uncrumple when valve 20 is compressed and uncompressed, respectively.
- the seats may comprise an elastic material, such as rubber silicone, that is configured to compress and stretch when valve 20 is compressed and uncompressed, respectively.
- Figs. 4A-C are schematic illustrations of a prosthetic valve 80, comprising a tubular element 82 and a valve member 84, in accordance with some applications of the invention.
- Fig. 4A shows valve 80 in a compressed configuration thereof
- Figs. 4B-C show valve 80 in an expanded configuration thereof, and functioning, in accordance with some applications of the invention.
- tubular element 82 comprises and/or has features of tubular element 22, described hereinabove (e.g., with reference to Figs. 1A-D).
- tubular element 82 defines a lumen 83 therethrough, typically comprises a frame that defines a plurality of cells, and is typically expandable (e.g., automatically) from a generally cylindrical compressed configuration (Fig. 4 A) to a generally cylindrical expanded configuration (Fig. 4B).
- valve member 84 comprises and/or has features of valve member 24, described hereinabove (e.g., with reference to Figs. 1A-D and/or 2A-B).
- valve member 84 is typically disc-shaped, typically comprises a frame that defines a plurality of cells, and is typically expandable (e.g., automatically) from a generally cylindrical compressed configuration (Fig. 4A) to a generally disc-shaped expanded configuration (Fig. 4B).
- valve 80 e.g., the dimensions of tubular element 82 and valve member 84
- valve 20 e.g., of tubular element 22 and valve member 24
- valve 84 in the generally cylindrical compressed configuration thereof, is typically disposed within lumen 83 of tubular element 82, in the generally cylindrical compressed configuration thereof.
- valve member 84 in the generally disc-shaped expanded configuration thereof, is disposed within lumen 83 of tubular element 82, in the generally cylindrical expanded configuration thereof.
- Valve 80 comprises covering 40, which covers at least part of the frames of tubular element 82 and valve member 84 (e.g., as described hereinabove for valve 20, mutatis mutandis).
- covering 40 covers an inner surface 96 of tubular element 82, and at least one side of valve member 84.
- Valve 80 is configured to be delivered percutaneously (e.g., transcatheterally and/or transluminally, such as transfemorally), e.g., as described hereinabove with respect to valve 20, mutatis mutandis.
- Valve member 84 is coupled to tubular element 82 at one or more (e.g., two) coupling points 100, in both the compressed and expanded configurations of valve 80.
- Coupling points 100 comprise a coupling element, which may comprise a hinge, a connector (e.g., a connecting wire or suture), or any other suitable coupling element.
- each coupling element of valve 80 comprises a protrusion of the frame of the valve member protruding into a slot defined by frame of the tubular element.
- Valve member 84 is coupled to tubular element 82 at the one or more coupling points 100, such that the valve member can move between (1) an open state in which the valve member generally allows fluid (e.g., blood) to flow through lumen 83, and (2) a closed state in which the valve member generally blocks lumen 83, thereby generally inhibiting fluid from flowing though the lumen.
- Fig. 4B shows valve member 84 (and thereby valve 80) in the closed state thereof
- Fig. 4C shows valve member 84 (and thereby valve 80) in the open state thereof.
- valve member 84 is coupled to tubular element 82 at two coupling points 100 (e.g., coupling points 100a and 100b), such that valve member 84 can deflect (e.g., bend) around an axis a3 between the two coupling points.
- coupling points 100a and 100b lie on a central transverse axis a4 (e.g., a diameter) of tubular element 82, and axis a3 acts as a central fixed axis around which each resulting half of valve member 84 deflects. Further typically, and as shown in Figs.
- the coupling element of valve 80 comprises a coupling rod 92, which is coupled to valve member 84 along axis a3, and to coupling points 100a and 100b, such that the valve member can move between the open and closed states by bending around the coupling rod.
- Coupling rod 92 is configured to be bent when valve 80 is compressed into the compressed configuration thereof (Fig. 4A), and to assume a generally straight configuration when the valve assumes the expanded configuration thereof (Figs. 4A-B).
- valve member 84 comprises valve member 24, described hereinabove.
- valve member 84 is unevenly rigid.
- valve member may define an area of increased flexibility at and/or around axis a3 (e.g., at and/or around coupling rod 92), so as to facilitate the movement of valve member 84 between the open and closed states described hereinabove.
- valve member 24 of prosthetic valve 20 typically moves between the open and closed states thereof without changing shape
- valve member 84 of prosthetic valve 80 typically does change shape when moving between the open and closed states thereof.
- Valve 80 is configured such that valve member 84 moves between the open state and the closed state in response to changes in relative fluid pressure between each end of lumen 83, and thereby valve 80 is configured to act as a one way valve (e.g., a check valve).
- a first end 104 of tubular element 82 is in fluid communication with a second end 106 of the tubular element.
- fluid communication between the two ends is reduced, compared to in the open state (e.g., the first and second ends are substantially not in fluid communication).
- valve member 84 when fluid pressure at a second end 106 of tubular member 82 is higher than fluid pressure at a first end 104 of the tubular member (e.g., when fluid "tries” to move from the second end to the first end), valve member 84 is in (e.g., moves into) the closed state, thereby inhibiting flow of the fluid from the second end to the first end.
- valve member 84 when fluid pressure at first end 104 is higher than fluid pressure at second end 106 (e.g., when fluid "tries” to move from the first end to the second end), valve member 84 moves into the open state, thereby facilitating flow of the fluid from the first end to the second end.
- valve 80 acts as a check-valve
- first end 104 is an upstream end of the valve
- second end 106 is a downstream end of the valve.
- valve member 84 movement of valve member 84 between the open and closed states thereof is driven primarily by the relative pressure at each end of lumen 83.
- valve member 84 is biased (e.g., shape-set) toward assuming the closed state, e.g., in the absence of any substantial forces thereon.
- Valve member 84 is typically configured (e.g., dimensioned) such that, in the closed state, an outer edge 90 of the valve member is disposed close to inner surface 96 of tubular element 82 (e.g., the valve member is in close contact with the inner surface of the tubular element).
- the diameter of valve member 84 is typically no more than 20% smaller than the width of the lumen of the tubular element.
- valve 80 further comprises a valve seat 102, configured to facilitate contact (e.g., sealing) between valve member 84 and tubular element 82.
- seat 102 is annular, and is disposed on the inner surface of tubular element 82, slightly closer than coupling points 100 to first end 104 of the tubular element.
- Seat 102 protrudes into lumen 83 of tubular element 82, so as to facilitate sealing between the tubular element and valve member 84.
- the seats comprise a sealing element, such as a sealing surface, to further facilitate such sealing.
- the seat and/or sealing element comprises a fabric, a resin and/or a polymer and is configured to fold, crumple, contract, and/or compress when valve 80 is compressed into the compressed configuration thereof (Fig. 4A), and to unfold, uncrumple, expand, and/or uncompress into the configuration shown in Figs. 4B-C, when valve 80 is moved into the uncompressed configuration.
- the seat may comprise a fabric, sutured to the frame of tubular element 82, and configured to crumple and uncrumple when valve 80 is compressed and uncompressed, respectively.
- the seat may comprise an elastic material, such as rubber silicone, that is configured to compress and stretch when valve 80 is compressed and uncompressed, respectively.
- FIGs. 5A-C are schematic illustrations of a prosthetic valve 120, comprising a tubular element 122 and a valve member 124, in accordance with some applications of the invention.
- Fig. 5A shows valve 120 in a compressed configuration thereof
- Figs. 5B-C show valve 120 in an expanded configuration thereof, and functioning, in accordance with some applications of the invention.
- tubular element 122 comprises and/or has features of tubular element 22 and/or tubular element 82, described hereinabove (e.g., with reference to Figs. 1A-D, and/or 4A-C).
- tubular element 122 defines a lumen 123 therethrough, typically comprises a frame that defines a plurality of cells, and is typically expandable (e.g., automatically) from a generally cylindrical compressed configuration (Fig. 5A) to a generally cylindrical expanded configuration (Fig. 5B).
- valve member 124 comprises and/or has features of valve member 24 and/or valve member 84, described hereinabove (e.g., with reference to Figs. 1A-D, 2A-B and/or 4A-C).
- valve member 124 is typically disc-shaped, typically comprises a frame that defines a plurality of cells, and is typically expandable (e.g., automatically) from a generally cylindrical compressed configuration (Fig. 5A) to a generally disc-shaped expanded configuration (Fig. 5B).
- valve 120 e.g., the dimensions of tubular element 122 and valve member 124) are similar (e.g., the same as) those of valve 20 (e.g., of tubular element 22 and valve member 24), described hereinabove, mutatis mutandis.
- valve member 12 in the compressed configuration of valve 120, valve member
- valve member 124 in the generally cylindrical compressed configuration thereof, is typically disposed within lumen 123 of tubular element 122, in the generally cylindrical compressed configuration thereof.
- valve member 124 in the generally disc-shaped expanded configuration thereof, is disposed within lumen 123 of tubular element 122, in the generally cylindrical expanded configuration thereof.
- Valve 120 comprises covering 40, which covers at least part of the frames of tubular element 122 and valve member 124 (e.g., as described hereinabove for valves 20 and 80, mutatis mutandis).
- covering 40 covers an inner surface 136 of tubular element 82, and at least one side of valve member 84.
- Valve 80 is configured to be delivered percutaneously (e.g., transcatheterally and/or transluminally, such as transfemorally), e.g., as described hereinabove with respect to valves 20 and 80, mutatis mutandis.
- Valve member 124 is coupled to tubular element 122 at at least one coupling point 140, in both the compressed and expanded configurations of valve 120.
- Valve 120 comprises a coupling element 141, which may comprise a hinge, a connector (e.g., a connecting wire or suture), or any other suitable coupling element.
- coupling element 141 comprises one or more struts 150 that protrude radially-inwardly from tubular element 122, and are coupled to a generally central point on valve member 124 (e.g., generally midway across the diameter of the valve member).
- coupling element 141 comprises another strut 152 that is coupled to struts 150, extends longitudinally from struts 150, and couples struts 150 to valve member 124 by being coupled to the valve member.
- Valve member 124 is coupled to tubular element 122 such that the valve member can move between (1) an open state in which the valve member generally allows fluid (e.g., blood) to flow through lumen 123, and (2) a closed state in which the valve member generally blocks lumen 123, thereby generally inhibiting fluid from flowing though the lumen.
- Fig. 5B shows valve member 124 (and thereby valve 120) in the closed state thereof
- Fig. 5C shows valve member 124 (and thereby valve 120) in the open state thereof.
- valve member 124 is coupled to tubular element 122 at coupling point 140 such that valve member 124 can deflect (e.g., bend, fold, and/or collapse) from the coupling point, such as by opening and closing in an umbrella-like or jellyfish-like fashion.
- coupling point 140 lies on a central longitudinal axis a5 of tubular element 122 and at the center of valve member 124. It is to be noted that, whereas valve member 24 of prosthetic valve 20 typically moves between the open and closed states thereof without changing shape, valve member 124 of prosthetic valve 120 typically does change shape when moving between the open and closed states thereof.
- valve member 124 comprises valve member 24 and/or valve member 84, described hereinabove.
- valve member 124 is unevenly rigid.
- the valve member may define one or more areas of increased flexibility that extend radially from coupling point 140 so as to facilitate the movement of valve member 124 between the open and closed states described hereinabove.
- Valve 120 is configured such that valve member 124 moves between the open state and the closed state in response to changes in relative fluid pressure between each end of lumen 123, and thereby valve 120 is configured to act as a one way valve (e.g., a check valve).
- a one way valve e.g., a check valve
- a first end 144 of tubular element 122 is in fluid communication with a second end 146 of the tubular element.
- the closed state fluid communication between the two ends is reduced, compared to in the open state (e.g., the first and second ends are substantially not in fluid communication).
- Fig. 5B when fluid pressure at a second end 146 of tubular member
- valve member 124 is in (e.g., moves into) the closed state, thereby inhibiting flow of the fluid from the second end to the first end.
- valve member 124 moves into the open state, thereby facilitating flow of the fluid from the first end to the second end.
- valve 120 acts as a check-valve
- first end 144 is an upstream end of the valve
- second end 146 is a downstream end of the valve.
- valve member 124 movement of valve member 124 between the open and closed states thereof is driven primarily by the relative pressure at each end of lumen 123.
- valve member 124 is biased (e.g., shape-set) toward assuming the closed state, e.g., in the absence of any substantial forces thereon.
- Valve member 124 is typically configured (e.g., dimensioned) such that, in the closed state, an outer edge 130 of the valve member is disposed close to inner surface 136 of tubular element 122 (e.g., the valve member is in close contact with the inner surface of the tubular element).
- the diameter of valve member 124 is typically no more than 20% smaller than the width of the lumen of the tubular element.
- valve 120 further comprises a valve seat 142, configured to facilitate contact (e.g., sealing) between valve member 124 and tubular element 122.
- seat 142 is annular, and is disposed on the inner surface of tubular element 122.
- Seat 142 protrudes into lumen 123 of tubular element 122, so as to facilitate sealing between the tubular element and valve member 124.
- the seats comprise a sealing element, such as a sealing surface, to further facilitate such sealing.
- the seat and/or sealing element comprises a fabric, a resin and/or a polymer and is configured to fold, crumple, contract, and/or compress when valve 120 is compressed into the compressed configuration thereof (Fig. 5A), and to unfold, uncrumple, expand, and/or uncompress into the configuration shown in Figs. 5B-C, when valve 120 is moved into the uncompressed configuration.
- the seat may comprise a fabric, sutured to the frame of tubular element 122, and configured to crumple and uncrumple when valve 120 is compressed and uncompressed, respectively.
- the seat may comprise an elastic material, such as rubber silicone, that is configured to compress and stretch when valve 120 is compressed and uncompressed, respectively.
- the prosthetic valves described hereinabove are typically configured to be compressed (e.g., crimped) so as to have a greatest diameter of less than 12 mm (e.g., less than 9 mm, such as less than 6 mm).
- the prosthetic valves described hereinabove are thereby typically advantageously configured to be delivered via a catheter that is 34 Fr or narrower (e.g., 24 Fr or narrower, such as 18 Fr or narrower), thereby facilitating percutaneous (e.g., transluminal, such as transfemoral) delivery.
- a catheter that is 34 Fr or narrower (e.g., 24 Fr or narrower, such as 18 Fr or narrower), thereby facilitating percutaneous (e.g., transluminal, such as transfemoral) delivery.
- percutaneous e.g., transluminal, such as transfemoral
- the valve member of each prosthetic valve is typically disposed within the lumen of the tubular element of that prosthetic valve, in both the compressed and uncompressed configurations of the prosthetic valve. It is to be noted that, for some applications, in the compressed configuration of the prosthetic valve, the valve member is disposed outside of the lumen of the tubular element. For example, in the compressed configuration of the prosthetic valve, the tubular element and the valve member may be generally collinear.
- the valve member of each prosthetic valve is typically coupled to the tubular element of that prosthetic valve, in both the compressed and uncompressed configurations of the prosthetic valve (e.g., during delivery and after implantation).
- the valve member is intracorporeally couplable to the tubular element, such as after implantation of the tubular element.
- the tubular element and valve member may be delivered sequentially, whilst connected via one or more guiding filaments, the guiding filaments facilitating juxtaposition and coupling of tubular element and valve member, such as by facilitating assembly of coupling element (e.g., by guiding a protrusion or rod into a slot).
- the prosthetic valves described herein are implanted (and/or configured to be implanted) at a native valve of the subject such that the first end is upstream of the second end.
- the valves may be implanted at an atrioventricular valve of the subject (e.g., a mitral valve of the subject) such that the first end is disposed in an atrium of the subject (e.g., a left atrium of the subject) and the second end is disposed in a ventricle of the subject (e.g., a left ventricle of the subject).
- the prosthetic valve replaces one-way valve functionality of the native valve, with one-way valve functionality of the prosthetic valve.
Abstract
Apparatus for regulating blood flow of a subject is provided, the apparatus comprising a prosthetic valve (20) that comprises a tubular element (22), shaped to define a lumen (23) therethrough, and a valve member (24), configured to be coupled to the tubular element (22) and to be disposed within the lumen (23). The prosthetic valve (20) has (1) a compressed configuration in which the lumen (23) has a compressed width, the valve member (24) is generally cylindrical, and the prosthetic valve (20) is configured to be percutaneously delivered into the subject, and (2) an expanded configuration in which the lumen (23) has an expanded width that is greater than the compressed width, and the valve member (24) is generally disc-shaped, is coupled to the tubular element (22), and is disposed within the lumen (23). Other embodiments are also described.
Description
PERCUTANEQUSLY-DELIVERABLE MECHANICAL VALVE
CROSS-REFERENCES TO RELATED APPLICATIONS
The present application claims priority from US Patent Application 13/675,119 to HaCohen et al., entitled, "Percutaneously-deliverable mechanical valve," filed on November 13, 2012, which is incorporated herein by reference.
FIELD OF THE INVENTION
Some applications of the present invention relate in general to valve replacement. More specifically, some applications of the present invention relate to prosthetic valves for replacement of a cardiac valve. BACKGROUND
Ischemic heart disease causes regurgitation of a heart valve by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the valve annulus. Dilation of the annulus of the valve prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.
SUMMARY OF THE INVENTION
A percutaneously-deliverable (e.g., transluminally-deliverable) mechanical prosthetic valve, comprising a tubular element and a valve member is described. Typically, the tubular element and valve member are restrained in respective compressed configurations for delivery, and automatically expand into respective expanded configurations when released at the native valve. There is therefore provided, in accordance with an application of the present invention, apparatus for regulating blood flow of a subject, the apparatus including a prosthetic valve, the prosthetic valve:
including:
a tubular element, shaped to define a lumen therethrough, and
a valve member, configured to be coupled to the tubular element and to be disposed within the lumen, and
having:
a compressed configuration in which the lumen has a compressed width, the valve member is generally cylindrical, and the prosthetic valve is configured to be percutaneously delivered into the subject, and
an expanded configuration in which:
the lumen has an expanded width that is greater than the compressed width, and
the valve member is generally disc-shaped, is coupled to the tubular element, and is disposed within the lumen.
In an application, the prosthetic valve is configured to function as a check valve when in the expanded configuration thereof, and not when in the compressed configuration thereof. In an application, in the compressed configuration, the valve member is coupled to the tubular element.
In an application, in the compressed configuration, the valve member is disposed within the lumen.
In an application:
the lumen has a first end and a second end, and
the valve member, when the valve is in the expanded configuration thereof:
has an open state, in which the first and second ends of the lumen are in fluid communication with each other,
has a closed state, in which the first and second ends of the lumen are generally not in fluid communication with each other, and
is movable between the open and closed states.
In an application, in the expanded configuration, the valve member is configured to move between the open and closed states in response to changes in relative pressure between the first and second ends of the lumen. In an application, in the expanded configuration, the valve member, in at least the closed state thereof, has a diameter that is no more than 20 percent smaller than the expanded width of the lumen.
In an application, the valve member has a compressed diameter in the compressed configuration of the prosthetic valve, and an expanded diameter in the in the expanded configuration of the prosthetic valve, and the expanded diameter is at least twice as great as the compressed diameter. In an application, in the expanded configuration, the prosthetic valve is configured to act as a check valve.
In an application, in the expanded configuration, the valve member is configured to move toward the open state when pressure at the first end of the lumen is greater than pressure at the second end of the lumen, and to move toward the closed state when pressure at the second end of the lumen is greater than pressure at the first end of the lumen.
In an application, the valve member is coupled to the tubular element at at least two coupling points, the coupling points defining an axis therebetween.
In an application, the valve member is configured to move between the open and closed states thereof, by rotating around the axis between the coupling points.
In an application, the valve member is configured to move between the open and closed states thereof, by deflecting around the axis between the coupling points.
In an application, the apparatus further includes a coupling rod, coupled to the coupling points, and coupled to the valve member along the axis between the coupling points, and the valve member is configured to move between the open and closed states thereof, by bending around the coupling rod.
In an application, the prosthetic valve includes a coupling element that includes at least one strut, the strut being coupled to the tubular element, and to the valve member at a coupling point that is generally midway across a diameter of the valve member, and the valve member is configured to move between the open and closed states by deflecting from the coupling point.
In an application, the valve member is configured to move between the open and closed states by collapsing and expanding.
In an application, the valve member is configured to move between the open and closed states thereof without changing a shape thereof.
In an application, the prosthetic valve is configured such that, when the valve member moves toward the open state, at least part of the valve member moves toward the first end of the lumen and at least part of the valve member moves toward the second end of the lumen. In an application, the valve member is configured to move between the open and closed states thereof by changing a shape thereof.
In an application, the valve member is configured to be biased toward being in the closed state thereof.
In an application, in the compressed configuration, the prosthetic valve has a greatest transverse diameter of less than 12 mm.
In an application, in the compressed configuration, the prosthetic valve has a greatest transverse diameter of less than 9 mm.
In an application, in the compressed configuration, the prosthetic valve has a greatest transverse diameter of less than 6 mm. In an application, the prosthetic valve is intracorporeally expandable from the compressed configuration to the expanded configuration.
In an application, the prosthetic valve is configured to be percutaneously delivered in the constrained configuration thereof, by being restrained in the compressed configuration during the percutaneous delivery, and the prosthetic valve is configured to automatically expand toward the expanded configuration thereof when no longer restrained.
The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
BRIEF DESCRIPTION OF THE DRAWINGS
Figs. 1A-D are schematic illustrations of a prosthetic valve, comprising a tubular element and a valve member, in accordance with some applications of the invention;
Figs. 2A-B are schematic illustrations of the valve member, in accordance with respective applications of the invention;
Figs. 3A-B are schematic illustrations of a prosthetic valve in open and closed states thereof, in accordance with some applications of the invention;
Figs. 4A-C are schematic illustrations of a prosthetic valve, comprising a tubular element and a valve member, in accordance with some applications of the invention; and
Figs. 5A-C are schematic illustrations of a prosthetic valve comprising a tubular element and a valve member, in accordance with some applications of the invention. DETAILED DESCRIPTION OF EMBODIMENTS
Reference is made to Figs. 1A-D, which are schematic illustrations of a prosthetic valve 20, comprising a tubular element 22 and a valve member 24, in accordance with some applications of the invention. It is to be noted that throughout this application, including the specification and the claims, the term "valve member" is defined as the movable obstruction (e.g., inside the tubular element) that restricts and/or controls flow through the valve, as is known in the general valve art. Prosthetic valve 20 is configured to be placed in a lumen of the body of the subject, such as in a blood vessel and/or at a native valve of the subject. Typically, prosthetic valve 20 is configured to be placed at a native heart valve of a subject, and to replace native functionality of the native valve. Fig. 1A shows tubular element 22 alone, Fig. IB shows valve member 24 alone, Fig. 1C shows valve 20 in a compressed configuration thereof, and Fig. ID shows valve 20 in an expanded configuration thereof, in accordance with some applications of the invention.
Fig. 1A shows tubular element 22, in an expanded configuration thereof, in accordance with some applications of the invention. Tubular element 22 is shaped to define a lumen 23 therethrough, and has a length dl along a longitudinal axis of the tubular element, from a first end of the lumen to a second end of the lumen (e.g., from a first end of element 22 to a second end of element 22). Lumen 23 is defined by an inner surface 36 (Fig. ID) of tubular element 22, and has a width d2. That is, d2 represents an inner width of tubular element 22. Typically, tubular element 22 is generally cylindrical (i.e., element 22 has a generally circular transverse cross- section), and width d2 represents a diameter of lumen 23. Alternatively, tubular element 22 has a transverse cross-section that is not generally circular, and width d2 represents a maximum width of lumen 23.
Typically, length dl is greater than 10 mm and/or less than 30 mm (e.g., 10-30 mm). Typically, width d2 is greater than 20 mm and/or less than 40 mm (e.g., 20-40 mm, such as 30 mm). That is, in the expanded configuration thereof (as shown in Fig. 1A), tubular element 22 has length of greater than 10 mm and/or less than 30 mm, and an inner width of greater than 20 mm and/or less than 40 mm.
Typically, tubular member 22 comprises a frame 26 that defines a circumferentially-repeating arrangement of cells 27. Typically, frame 26 defines, along length dl, longitudinal columns cl comprising one cell 27, alternating with longitudinal columns c2 comprising two cells. Typically, frame 26 defines circumferential rows comprising more than 10 and/or less than 25 cells 27 (e.g., 18 cells). It is to be noted, however, that the scope of the invention includes other configurations of frame 26.
Fig. IB shows valve member 24, in an expanded configuration thereof, in accordance with some applications of the invention. Valve member 24 typically has a shape that is similar to that of lumen 23 of tubular element 22. That is, a transverse cross- section of valve member 24 typically has a shape that is similar to the shape of the transverse cross-section of lumen 23. For example, for applications in which tubular element 22 is generally cylindrical, valve member 24 typically has a generally disc-shaped transverse cross-section. For such applications, other dimensions and/or shapes of valve member 24 may vary (e.g., as described with reference to Figs. 2A-B). Typically, valve member 24 has a width d4 that is no more than 20% smaller than width d2 of tubular element 22 (e.g., no more than 10% smaller, such as no more than 5% smaller). For applications in which tubular element 22 is generally cylindrical and valve member is generally disc-shaped, widths d3 and d4 represent transverse cross-sectional diameters of lumen 23 and valve member 24, respectively, and the diameter of valve member 24 is typically no less than 20% smaller than the diameter of lumen 23 (i.e., no less than 20% smaller than the inner diameter of tubular element 22). Thereby, width d4 is typically greater than 20 mm and/or less than 40 mm (e.g., 20-40 mm, such as 30 mm).
Typically, valve member 24 comprises a frame 28 that defines an outer edge 30, an inner edge 32, and a radially-repeating arrangement of cells 29, disposed between the inner and outer edges. Inner edge 32 defines an opening 42, the presence of which facilitates compression of valve member 24 into the compressed configuration thereof (e.g., as described with reference to Fig. 1C). That is, the absence of frame material at opening 42 facilitates compression of the valve member into a generally cylindrical shape. Typically, opening 42 has a width d5 (e.g., a diameter) of more than 5 mm and/or less than 20 mm (e.g., between 5 and 20 mm, such as 12 mm). Alternatively or additionally, frame 28 may comprise a portion of increased flexibility, e.g., instead of defining opening 42.
For clarity, Figs. 1A-B show frames 26 and 28 of tubular element 22 and valve member 24, respectively. However, tubular element 22 and valve member 24 comprise a covering 40, e.g., as shown in Figs. 1C-D. Covering 40 covers at least part of frames 26 and 28. Non-limiting examples of materials that covering 40 may comprise, include cotton and polymers (e.g., polyester). Typically the covering has a thickness that is less than 1 mm (e.g., between 0.05 mm and 0.6 mm).
Fig. 1C shows valve 20 in the compressed configuration thereof, in which valve member 24, in a compressed configuration thereof, is disposed within lumen 23 of tubular element 22, in the compressed configuration thereof. Fig. ID shows valve 20 in the expanded configuration thereof, in which valve member 24, in an expanded configuration thereof, is disposed within lumen 23 of tubular element 22, in an expanded configuration thereof.
Valve 20 is configured to be percutaneously (e.g., transcatheterally and/or transluminally, such as transfemorally) delivered to the native heart valve of a subject, by being compressed (e.g., "crimped") into the compressed configuration thereof (i.e., a delivery configuration thereof). Valve 20 is typically configured to be restrained in the compressed configuration (e.g., by an overtube) during delivery of the valve, and to automatically move into an expanded configuration when released (e.g., by being deployed from the overtube). Typically, frames 26 and 28 comprise a shape-memory material such as, but not limited to, nitinol, which facilitates this automatic expansion.
Covering 40 typically covers inner surface 36 of cylindrical element 22 and at least one side of valve member 24, including opening 42. Opening 42 is thereby an opening in frame 28 but typically not an opening in covering 40, and thereby typically not an opening through the entire of valve member 24 (Fig. ID). As described hereinabove, tubular element 22 is typically generally cylindrical.
That is, element 22 is typically generally cylindrical in the expanded configuration thereof. Tubular element 22 is typically also generally cylindrical in the compressed configuration thereof. In the compressed configuration thereof, tubular element 22 (e.g., lumen 23 thereof) has a width d6 (e.g., a diameter) that is smaller than width d2 of the tubular element in the compressed configuration thereof. Typically, width d2 is more than 1.5 times (e.g., more than 4 times) greater than width d6.
As described hereinabove, valve member 24 is typically generally disc-shaped. That is, member 24 is typically generally disc-shaped in the expanded configuration thereof. In the compressed configuration thereof, valve member 24 is typically elongate, such as generally cylindrical, and has a width (e.g., a diameter) d7. Typically, width d4 (Fig. IB) is more than twice (e.g., more than 5 times, such as more than 10 times) greater than width d7. Typically, when valve member 24 moves from the compressed configuration to the expanded configuration, (1) a first end 33 of the cylinder defined by valve member 24 in the compressed configuration, expands to define outer edge 30 of the valve member in the expanded configuration, and a second end 35 of the cylinder expands to define inner edge 32. It is to be noted that covering 40 covers opening 42 in frame 28, and therefore inner edge 32 is an inner edge of frame 28, and does not define an opening through the entire of valve member 24.
Valve member 24 is typically disposed in lumen 23 of tubular element 22, in both the compressed configuration and the expanded configuration of valve 20. Valve member 24 is coupled to tubular element 22 at one or more (e.g., two) coupling points 60. Coupling points 60 comprise a coupling element 61, which may comprise a hinge, a connector (e.g., a connecting wire or suture), or any other suitable coupling element. For some applications, and as shown in Fig. ID, coupling element 61 comprises a hinge formed by a protrusion 59 of frame 28 protruding into a slot 57 defined by frame 26. Typically, and as described in more detail with reference to Figs. 3A-B, valve 20 further comprises one or more valve seats 62, configured to facilitate sealing between tubular element 22 and valve member 24.
Typically, width d6 is greater than 2 mm and/or less than 12 mm (e.g., 2-10 mm, such as 3-6 mm). Typically, width d7 is greater than 2 mm and/or less than 10 mm (e.g., 2-8 mm, such as 2-6 mm). Typically, valve member 24 is configured to be compressible such that width d7 is smaller than width d6 in a maximally-compressed configuration of cylindrical element 22, e.g., such that cylindrical element 22 is compressible to generally the same width in the presence or absence of valve member 24.
As described hereinabove, prosthetic valve 20 is configured to be placed (i.e., implanted) at a native heart valve of a subject, and to replace native functionality of the native valve. Prosthetic valve 20 is configured to act as a one-way valve (e.g., a check valve). That is, prosthetic valve 20 is configured to generally allow blood to flow in a first direction through lumen 23 of tubular element 22, and to inhibit blood from flowing in a
second direction through the lumen. Typically, prosthetic valve 20 resembles and/or is configured to act as a "tilting disc" valve, as is known in the valve art. Valve member 24, disposed in lumen 23 of tubular element 22, provides valve functionality by being configured to move between an open state and a closed state in response to changes in relative pressure between each end of the lumen of tubular element 22 (i.e., in response to changes in relative pressure between blood at each end of the lumen; e.g., as described hereinbelow with reference to Figs. 3A-B). Movement of valve member 24 between the open and closed states thereof, thereby moves prosthetic valve 20 between open and closed states thereof. Reference is made to Figs. 2A-B, which are schematic illustrations of valve member 24, in accordance with respective applications of the invention. As described hereinabove, valve member 24 is typically disc-shaped in the expanded configuration thereof. Fig. 2A shows valve member 24, comprising a disc-shaped valve member 24a in the expanded configuration thereof, in accordance with some applications of the invention. As described hereinabove, frame 28 and opening 42 of valve member 24 are typically covered in covering 40.
For some applications, valve member 24 has a shape that is different to a flat disc. Fig. 2B shows valve member 24, comprising a frustoconical valve member 24b in the expanded configuration thereof, in accordance with some applications of the invention. For some applications of the invention, frame 28 of valve member 24b comprises a frame 28b, which is configured to assume a frustoconical shape. For some applications of the invention, covering 40 of valve member 24b comprises a covering 40b, which is configured to facilitate the valve member assuming the frustoconical shape, e.g., by restricting full expansion of the frame. For some such applications, valve member 24b comprises frame 28 (i.e., the same frame as member 24a), and the assuming of the frustoconical shape of valve member 24b is facilitated mainly (e.g., solely) by covering 40b.
It is to be noted that Figs. 2A-B show non-limiting examples of possible shapes of valve member 24, and that the scope of the invention includes valve member 24 having other shapes. Similarly, it is to be noted that, although tubular element 22 is shown as being substantially cylindrical, the scope of the invention includes tubular element 22 having other shapes, e.g., so as to facilitate blood flow, so as to conform to the shape of the native valve, and/or so as to facilitate coupling to the native valve and/or to auxiliary
apparatus, such as a prosthetic valve support, such as the prosthetic valve supports described in US 2012/0022640 to Gross et al., which is incorporated herein by reference. For example, tubular element 22 may comprise and/or define flared ends, barbs, clips, or any other such features, e.g., as are known in the art. Reference is made to Figs. 3A-B, which are schematic illustrations of functioning of valve 20, in accordance with respective applications of the invention. Figs. 3A-B show valve member 24 as disc-shaped (e.g., as shown for valve member 24a, described with reference to Fig. 2A), but valve members of other shapes may be used, and typically function similarly, mutatis mutandis. Valve member 24 is coupled to tubular element 22 at one or more coupling points
60, such that the valve member can rotate between (1) an open state in which the valve member generally allows fluid (e.g., blood) to flow through lumen 23, and (2) a closed state in which the valve member generally blocks lumen 23, thereby generally inhibiting fluid from flowing through the lumen. Typically, valve member 24 is coupled to tubular element 22 at two coupling points 60 (e.g., coupling points 60a and 60b), such that the valve member can rotate around an axis al between the two coupling points. Typically, valve member 24 does not change shape when moving between the open and closed states. Fig. 3A shows valve member 24 (and thereby valve 20) in the closed state thereof, and Fig. 3B shows valve member 24 (and thereby valve 20) in the open state thereof. Typically, coupling points 60a and 60b do not lie on a central transverse axis a2 of tubular element 22. That is, axis al is typically a non-diameter chord of a transverse cross-section of tubular element 22. Such a configuration typically facilitates the functioning of valve 20 as a tilting-disc valve, as is known in the art.
Valve 20 is configured such that valve member 24 moves between the open state and the closed state in response to changes in relative fluid pressure between each end of lumen 23, and thereby valve 20 is configured to act as a one way valve (e.g., a check valve). In the open state, a first end 64 of tubular element 22 is in fluid communication with a second end 66 of the tubular element. In the closed state, fluid communication between the two ends is reduced, compared to in the open state (e.g., the first and second ends are substantially not in fluid communication).
As shown in Fig. 3A, when fluid pressure at a second end 66 of tubular member 22 is higher than fluid pressure at a first end 64 of the tubular member (e.g., when fluid
"tries" to move from the second end to the first end), valve member 24 is in (e.g., moves into) the closed state, thereby inhibiting flow of the fluid from the second end to the first end. As shown in Fig. 3B, when fluid pressure at first end 64 is higher than fluid pressure at second end 66 (e.g., when fluid "tries" to move from the first end to the second end), valve member 24 moves into the open state, thereby facilitating flow of the fluid from the first end to the second end. Thereby, valve 20 acts as a check-valve (e.g., a tilting-disc valve), first end 64 is an upstream end of the valve, and second end 66 is a downstream end of the valve. It is to be noted that, when the valve member moves toward the open state, part of valve member 24 moves toward first end 64 (i.e., upstream), and part of the valve member moves toward second end 66 (i.e., downstream).
Valve member 24 is typically configured (e.g., dimensioned) such that, in the closed state, outer edge 30 (see Fig. IB) of the valve member is positioned closely to the inner surface of tubular element 22 (e.g., the valve member is in close contact with the inner surface of the tubular element). For example, and as described hereinabove, the diameter of valve member 24 is typically no more than 20% smaller than the width of the lumen of the tubular element.
For some applications of the invention, valve 20 further comprises at least one valve seat 62, configured to facilitate contact (e.g., sealing) between valve member 24 and tubular element 22. For some such applications, and as shown in Figs. 3A-B, seat 62 comprises two arc-shaped seats 62a and 62b that are disposed on the inner surface of the tubular element, and form respective arcs whose endpoints are adjacent to coupling points 60a and 60b. For example, and as shown in Figs. 3A-B, (1) seat 62a forms a major arc between coupling points 60a and 60b, disposed slightly closer than coupling points 60 to first end 64, and (2) seat 62b forms a complementary minor arc, disposed slightly closer than coupling points 60 to second end 66.
Seats 62a and 62b protrude into lumen 23 of tubular element 22, so as to facilitate sealing between the tubular element and valve member 24. For some applications, the seats comprise a sealing element, such as a sealing surface, to further facilitate such sealing. Typically, the seats and/or sealing elements comprise a fabric, a resin and/or a polymer and are configured to fold, crumple, contract, and/or compress when valve 20 is compressed into the compressed configuration thereof, and to unfold, uncrumple, expand, and/or uncompress into the configuration shown in Figs. 3A-B, when valve 20 is moved into the uncompressed configuration thereof. For example, the seats may comprise a
fabric, sutured to frame 26, and configured to crumple and uncrumple when valve 20 is compressed and uncompressed, respectively. Alternatively or additionally, the seats may comprise an elastic material, such as rubber silicone, that is configured to compress and stretch when valve 20 is compressed and uncompressed, respectively. Reference is made to Figs. 4A-C, which are schematic illustrations of a prosthetic valve 80, comprising a tubular element 82 and a valve member 84, in accordance with some applications of the invention. Fig. 4A shows valve 80 in a compressed configuration thereof, and Figs. 4B-C show valve 80 in an expanded configuration thereof, and functioning, in accordance with some applications of the invention. Typically, tubular element 82 comprises and/or has features of tubular element 22, described hereinabove (e.g., with reference to Figs. 1A-D). For example, tubular element 82 defines a lumen 83 therethrough, typically comprises a frame that defines a plurality of cells, and is typically expandable (e.g., automatically) from a generally cylindrical compressed configuration (Fig. 4 A) to a generally cylindrical expanded configuration (Fig. 4B).
Typically, valve member 84 comprises and/or has features of valve member 24, described hereinabove (e.g., with reference to Figs. 1A-D and/or 2A-B). For example, valve member 84 is typically disc-shaped, typically comprises a frame that defines a plurality of cells, and is typically expandable (e.g., automatically) from a generally cylindrical compressed configuration (Fig. 4A) to a generally disc-shaped expanded configuration (Fig. 4B).
Typically, the dimensions of valve 80 (e.g., the dimensions of tubular element 82 and valve member 84) are similar (e.g., the same as) those of valve 20 (e.g., of tubular element 22 and valve member 24), described hereinabove, mutatis mutandis. As shown in Fig. 4A, in the compressed configuration of valve 80, valve member
84, in the generally cylindrical compressed configuration thereof, is typically disposed within lumen 83 of tubular element 82, in the generally cylindrical compressed configuration thereof. As shown in Fig. 4B, in the expanded configuration of valve 80, valve member 84, in the generally disc-shaped expanded configuration thereof, is disposed within lumen 83 of tubular element 82, in the generally cylindrical expanded configuration thereof.
Valve 80 comprises covering 40, which covers at least part of the frames of tubular element 82 and valve member 84 (e.g., as described hereinabove for valve 20, mutatis mutandis). Typically, covering 40 covers an inner surface 96 of tubular element 82, and at least one side of valve member 84. Valve 80 is configured to be delivered percutaneously (e.g., transcatheterally and/or transluminally, such as transfemorally), e.g., as described hereinabove with respect to valve 20, mutatis mutandis.
Valve member 84 is coupled to tubular element 82 at one or more (e.g., two) coupling points 100, in both the compressed and expanded configurations of valve 80. Coupling points 100 comprise a coupling element, which may comprise a hinge, a connector (e.g., a connecting wire or suture), or any other suitable coupling element. For some applications, and as described for coupling element 61 hereinabove, each coupling element of valve 80 comprises a protrusion of the frame of the valve member protruding into a slot defined by frame of the tubular element.
Valve member 84 is coupled to tubular element 82 at the one or more coupling points 100, such that the valve member can move between (1) an open state in which the valve member generally allows fluid (e.g., blood) to flow through lumen 83, and (2) a closed state in which the valve member generally blocks lumen 83, thereby generally inhibiting fluid from flowing though the lumen. Fig. 4B shows valve member 84 (and thereby valve 80) in the closed state thereof, and Fig. 4C shows valve member 84 (and thereby valve 80) in the open state thereof.
Typically, valve member 84 is coupled to tubular element 82 at two coupling points 100 (e.g., coupling points 100a and 100b), such that valve member 84 can deflect (e.g., bend) around an axis a3 between the two coupling points. Typically, coupling points 100a and 100b lie on a central transverse axis a4 (e.g., a diameter) of tubular element 82, and axis a3 acts as a central fixed axis around which each resulting half of valve member 84 deflects. Further typically, and as shown in Figs. 4A-C, the coupling element of valve 80 comprises a coupling rod 92, which is coupled to valve member 84 along axis a3, and to coupling points 100a and 100b, such that the valve member can move between the open and closed states by bending around the coupling rod. Coupling rod 92 is configured to be bent when valve 80 is compressed into the compressed configuration thereof (Fig. 4A), and to assume a generally straight configuration when the valve assumes the expanded configuration thereof (Figs. 4A-B).
For some applications of the invention, valve member 84 comprises valve member 24, described hereinabove. For some applications of the invention, valve member 84 is unevenly rigid. For example, the valve member may define an area of increased flexibility at and/or around axis a3 (e.g., at and/or around coupling rod 92), so as to facilitate the movement of valve member 84 between the open and closed states described hereinabove. It is to be noted that, whereas valve member 24 of prosthetic valve 20 typically moves between the open and closed states thereof without changing shape, valve member 84 of prosthetic valve 80 typically does change shape when moving between the open and closed states thereof. Valve 80 is configured such that valve member 84 moves between the open state and the closed state in response to changes in relative fluid pressure between each end of lumen 83, and thereby valve 80 is configured to act as a one way valve (e.g., a check valve). In the open state, a first end 104 of tubular element 82 is in fluid communication with a second end 106 of the tubular element. In the closed state, fluid communication between the two ends is reduced, compared to in the open state (e.g., the first and second ends are substantially not in fluid communication).
As shown in Fig. 4B, when fluid pressure at a second end 106 of tubular member 82 is higher than fluid pressure at a first end 104 of the tubular member (e.g., when fluid "tries" to move from the second end to the first end), valve member 84 is in (e.g., moves into) the closed state, thereby inhibiting flow of the fluid from the second end to the first end. As shown in Fig. 4C, when fluid pressure at first end 104 is higher than fluid pressure at second end 106 (e.g., when fluid "tries" to move from the first end to the second end), valve member 84 moves into the open state, thereby facilitating flow of the fluid from the first end to the second end. Thereby, valve 80 acts as a check-valve, first end 104 is an upstream end of the valve, and second end 106 is a downstream end of the valve.
For some applications of the invention, movement of valve member 84 between the open and closed states thereof is driven primarily by the relative pressure at each end of lumen 83. For some applications, valve member 84 is biased (e.g., shape-set) toward assuming the closed state, e.g., in the absence of any substantial forces thereon.
Valve member 84 is typically configured (e.g., dimensioned) such that, in the closed state, an outer edge 90 of the valve member is disposed close to inner surface 96 of
tubular element 82 (e.g., the valve member is in close contact with the inner surface of the tubular element). For example, the diameter of valve member 84 is typically no more than 20% smaller than the width of the lumen of the tubular element.
For some applications of the invention, valve 80 further comprises a valve seat 102, configured to facilitate contact (e.g., sealing) between valve member 84 and tubular element 82. For some such applications, and as shown in Figs. 4B-C, seat 102 is annular, and is disposed on the inner surface of tubular element 82, slightly closer than coupling points 100 to first end 104 of the tubular element. Seat 102 protrudes into lumen 83 of tubular element 82, so as to facilitate sealing between the tubular element and valve member 84. For some applications, the seats comprise a sealing element, such as a sealing surface, to further facilitate such sealing.
Typically, the seat and/or sealing element comprises a fabric, a resin and/or a polymer and is configured to fold, crumple, contract, and/or compress when valve 80 is compressed into the compressed configuration thereof (Fig. 4A), and to unfold, uncrumple, expand, and/or uncompress into the configuration shown in Figs. 4B-C, when valve 80 is moved into the uncompressed configuration. For example, the seat may comprise a fabric, sutured to the frame of tubular element 82, and configured to crumple and uncrumple when valve 80 is compressed and uncompressed, respectively. Alternatively or additionally, the seat may comprise an elastic material, such as rubber silicone, that is configured to compress and stretch when valve 80 is compressed and uncompressed, respectively.
Reference is made to Figs. 5A-C, which are schematic illustrations of a prosthetic valve 120, comprising a tubular element 122 and a valve member 124, in accordance with some applications of the invention. Fig. 5A shows valve 120 in a compressed configuration thereof, and Figs. 5B-C show valve 120 in an expanded configuration thereof, and functioning, in accordance with some applications of the invention.
Typically, tubular element 122 comprises and/or has features of tubular element 22 and/or tubular element 82, described hereinabove (e.g., with reference to Figs. 1A-D, and/or 4A-C). For example, tubular element 122 defines a lumen 123 therethrough, typically comprises a frame that defines a plurality of cells, and is typically expandable (e.g., automatically) from a generally cylindrical compressed configuration (Fig. 5A) to a generally cylindrical expanded configuration (Fig. 5B).
Typically, valve member 124 comprises and/or has features of valve member 24 and/or valve member 84, described hereinabove (e.g., with reference to Figs. 1A-D, 2A-B and/or 4A-C). For example, valve member 124 is typically disc-shaped, typically comprises a frame that defines a plurality of cells, and is typically expandable (e.g., automatically) from a generally cylindrical compressed configuration (Fig. 5A) to a generally disc-shaped expanded configuration (Fig. 5B).
Typically, the dimensions of valve 120 (e.g., the dimensions of tubular element 122 and valve member 124) are similar (e.g., the same as) those of valve 20 (e.g., of tubular element 22 and valve member 24), described hereinabove, mutatis mutandis. As shown in Fig. 5A, in the compressed configuration of valve 120, valve member
124, in the generally cylindrical compressed configuration thereof, is typically disposed within lumen 123 of tubular element 122, in the generally cylindrical compressed configuration thereof. As shown in Fig. 5B, in the expanded configuration of valve 120, valve member 124, in the generally disc-shaped expanded configuration thereof, is disposed within lumen 123 of tubular element 122, in the generally cylindrical expanded configuration thereof.
Valve 120 comprises covering 40, which covers at least part of the frames of tubular element 122 and valve member 124 (e.g., as described hereinabove for valves 20 and 80, mutatis mutandis). Typically, covering 40 covers an inner surface 136 of tubular element 82, and at least one side of valve member 84. Valve 80 is configured to be delivered percutaneously (e.g., transcatheterally and/or transluminally, such as transfemorally), e.g., as described hereinabove with respect to valves 20 and 80, mutatis mutandis.
Valve member 124 is coupled to tubular element 122 at at least one coupling point 140, in both the compressed and expanded configurations of valve 120. Valve 120 comprises a coupling element 141, which may comprise a hinge, a connector (e.g., a connecting wire or suture), or any other suitable coupling element. Typically, and as shown in Figs. 5A-C, coupling element 141 comprises one or more struts 150 that protrude radially-inwardly from tubular element 122, and are coupled to a generally central point on valve member 124 (e.g., generally midway across the diameter of the valve member). Further typically, coupling element 141 comprises another strut 152 that
is coupled to struts 150, extends longitudinally from struts 150, and couples struts 150 to valve member 124 by being coupled to the valve member.
Valve member 124 is coupled to tubular element 122 such that the valve member can move between (1) an open state in which the valve member generally allows fluid (e.g., blood) to flow through lumen 123, and (2) a closed state in which the valve member generally blocks lumen 123, thereby generally inhibiting fluid from flowing though the lumen. Fig. 5B shows valve member 124 (and thereby valve 120) in the closed state thereof, and Fig. 5C shows valve member 124 (and thereby valve 120) in the open state thereof. Typically, valve member 124 is coupled to tubular element 122 at coupling point 140 such that valve member 124 can deflect (e.g., bend, fold, and/or collapse) from the coupling point, such as by opening and closing in an umbrella-like or jellyfish-like fashion. Typically, coupling point 140 lies on a central longitudinal axis a5 of tubular element 122 and at the center of valve member 124. It is to be noted that, whereas valve member 24 of prosthetic valve 20 typically moves between the open and closed states thereof without changing shape, valve member 124 of prosthetic valve 120 typically does change shape when moving between the open and closed states thereof.
For some applications of the invention, valve member 124 comprises valve member 24 and/or valve member 84, described hereinabove. For some applications of the invention, valve member 124 is unevenly rigid. For example, the valve member may define one or more areas of increased flexibility that extend radially from coupling point 140 so as to facilitate the movement of valve member 124 between the open and closed states described hereinabove.
Valve 120 is configured such that valve member 124 moves between the open state and the closed state in response to changes in relative fluid pressure between each end of lumen 123, and thereby valve 120 is configured to act as a one way valve (e.g., a check valve). In the open state, a first end 144 of tubular element 122 is in fluid communication with a second end 146 of the tubular element. In the closed state, fluid communication between the two ends is reduced, compared to in the open state (e.g., the first and second ends are substantially not in fluid communication). As shown in Fig. 5B, when fluid pressure at a second end 146 of tubular member
122 is higher than fluid pressure at a first end 144 of the tubular member (e.g., when fluid "tries" to move from the second end to the first end), valve member 124 is in (e.g., moves
into) the closed state, thereby inhibiting flow of the fluid from the second end to the first end. As shown in Fig. 5C, when fluid pressure at first end 144 is higher than fluid pressure at second end 146 (e.g., when fluid "tries" to move from the first end to the second end), valve member 124 moves into the open state, thereby facilitating flow of the fluid from the first end to the second end. Thereby, valve 120 acts as a check-valve, first end 144 is an upstream end of the valve, and second end 146 is a downstream end of the valve.
For some applications of the invention, movement of valve member 124 between the open and closed states thereof is driven primarily by the relative pressure at each end of lumen 123. For some applications, valve member 124 is biased (e.g., shape-set) toward assuming the closed state, e.g., in the absence of any substantial forces thereon.
Valve member 124 is typically configured (e.g., dimensioned) such that, in the closed state, an outer edge 130 of the valve member is disposed close to inner surface 136 of tubular element 122 (e.g., the valve member is in close contact with the inner surface of the tubular element). For example, the diameter of valve member 124 is typically no more than 20% smaller than the width of the lumen of the tubular element.
For some applications of the invention, valve 120 further comprises a valve seat 142, configured to facilitate contact (e.g., sealing) between valve member 124 and tubular element 122. For some such applications, and as shown in Figs. 5B-C, seat 142 is annular, and is disposed on the inner surface of tubular element 122. Seat 142 protrudes into lumen 123 of tubular element 122, so as to facilitate sealing between the tubular element and valve member 124. For some applications, the seats comprise a sealing element, such as a sealing surface, to further facilitate such sealing.
Typically, the seat and/or sealing element comprises a fabric, a resin and/or a polymer and is configured to fold, crumple, contract, and/or compress when valve 120 is compressed into the compressed configuration thereof (Fig. 5A), and to unfold, uncrumple, expand, and/or uncompress into the configuration shown in Figs. 5B-C, when valve 120 is moved into the uncompressed configuration. For example, the seat may comprise a fabric, sutured to the frame of tubular element 122, and configured to crumple and uncrumple when valve 120 is compressed and uncompressed, respectively. Alternatively or additionally, the seat may comprise an elastic material, such as rubber
silicone, that is configured to compress and stretch when valve 120 is compressed and uncompressed, respectively.
Reference is again made to Figs. 1A-5C. The prosthetic valves described hereinabove are typically configured to be compressed (e.g., crimped) so as to have a greatest diameter of less than 12 mm (e.g., less than 9 mm, such as less than 6 mm). The prosthetic valves described hereinabove are thereby typically advantageously configured to be delivered via a catheter that is 34 Fr or narrower (e.g., 24 Fr or narrower, such as 18 Fr or narrower), thereby facilitating percutaneous (e.g., transluminal, such as transfemoral) delivery. Reference is again made to Figs. 1A-5C. As described hereinabove, the valve member of each prosthetic valve is typically disposed within the lumen of the tubular element of that prosthetic valve, in both the compressed and uncompressed configurations of the prosthetic valve. It is to be noted that, for some applications, in the compressed configuration of the prosthetic valve, the valve member is disposed outside of the lumen of the tubular element. For example, in the compressed configuration of the prosthetic valve, the tubular element and the valve member may be generally collinear.
Reference is again made to Figs. 1A-5C. As described hereinabove, the valve member of each prosthetic valve is typically coupled to the tubular element of that prosthetic valve, in both the compressed and uncompressed configurations of the prosthetic valve (e.g., during delivery and after implantation). It is to be noted that, for some applications, the valve member is intracorporeally couplable to the tubular element, such as after implantation of the tubular element. For example, the tubular element and valve member may be delivered sequentially, whilst connected via one or more guiding filaments, the guiding filaments facilitating juxtaposition and coupling of tubular element and valve member, such as by facilitating assembly of coupling element (e.g., by guiding a protrusion or rod into a slot).
Typically, the prosthetic valves described herein are implanted (and/or configured to be implanted) at a native valve of the subject such that the first end is upstream of the second end. For example, the valves may be implanted at an atrioventricular valve of the subject (e.g., a mitral valve of the subject) such that the first end is disposed in an atrium of the subject (e.g., a left atrium of the subject) and the second end is disposed in a ventricle of the subject (e.g., a left ventricle of the subject). Thereby, the prosthetic valve
replaces one-way valve functionality of the native valve, with one-way valve functionality of the prosthetic valve.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
Claims
1. Apparatus for regulating blood flow of a subject, the apparatus comprising a prosthetic valve, the prosthetic valve:
comprising:
a tubular element, shaped to define a lumen therethrough, and a valve member, configured to be coupled to the tubular element and to be disposed within the lumen, and
having:
a compressed configuration in which the lumen has a compressed width, the valve member is generally cylindrical, and the prosthetic valve is configured to be percutaneously delivered into the subject, and
an expanded configuration in which:
the lumen has an expanded width that is greater than the compressed width, and
the valve member is generally disc-shaped, is coupled to the tubular element, and is disposed within the lumen.
2. The apparatus according to claim 1, wherein the prosthetic valve is configured to function as a check valve when in the expanded configuration thereof, and not when in the compressed configuration thereof.
3. The apparatus according to claim 1, wherein, in the compressed configuration, the valve member is coupled to the tubular element.
4. The apparatus according to claim 1, wherein, in the compressed configuration, the valve member is disposed within the lumen.
5. The apparatus according to any one of claims 1-4, wherein:
the lumen has a first end and a second end, and
the valve member, when the valve is in the expanded configuration thereof:
has an open state, in which the first and second ends of the lumen are in fluid communication with each other,
has a closed state, in which the first and second ends of the lumen are generally not in fluid communication with each other, and
is movable between the open and closed states.
6. The apparatus according to claim 5, wherein, in the expanded configuration, the valve member is configured to move between the open and closed states in response to changes in relative pressure between the first and second ends of the lumen.
7. The apparatus according to claim 5, wherein, in the expanded configuration, the valve member, in at least the closed state thereof, has a diameter that is no more than 20 percent smaller than the expanded width of the lumen.
8. The apparatus according to claim 5, wherein the valve member has a compressed diameter in the compressed configuration of the prosthetic valve, and an expanded diameter in the in the expanded configuration of the prosthetic valve, and wherein the expanded diameter is at least twice as great as the compressed diameter.
9. The apparatus according to claim 5, wherein, in the expanded configuration, the prosthetic valve is configured to act as a check valve.
10. The apparatus according to claim 9, wherein, in the expanded configuration, the valve member is configured to move toward the open state when pressure at the first end of the lumen is greater than pressure at the second end of the lumen, and to move toward the closed state when pressure at the second end of the lumen is greater than pressure at the first end of the lumen.
11. The apparatus according to claim 5, wherein the valve member is coupled to the tubular element at at least two coupling points, the coupling points defining an axis therebetween.
12. The apparatus according to claim 11, wherein the valve member is configured to move between the open and closed states thereof, by rotating around the axis between the coupling points.
13. The apparatus according to claim 11, wherein the valve member is configured to move between the open and closed states thereof, by deflecting around the axis between the coupling points.
14. The apparatus according to claim 11, further comprising a coupling rod, coupled to the coupling points, and coupled to the valve member along the axis between the coupling points, wherein the valve member is configured to move between the open and closed states thereof, by bending around the coupling rod.
15. The apparatus according to claim 5, wherein the prosthetic valve comprises a coupling element that comprises at least one strut, the strut being coupled to the tubular element, and to the valve member at a coupling point that is generally midway across a diameter of the valve member, and wherein the valve member is configured to move between the open and closed states by deflecting from the coupling point.
16. The apparatus according to claim 15, wherein the valve member is configured to move between the open and closed states by collapsing and expanding.
17. The apparatus according to claim 5, wherein the valve member is configured to move between the open and closed states thereof without changing a shape thereof.
18. The apparatus according to claim 5, wherein the prosthetic valve is configured such that, when the valve member moves toward the open state, at least part of the valve member moves toward the first end of the lumen and at least part of the valve member moves toward the second end of the lumen.
19. The apparatus according to claim 5, wherein the valve member is configured to move between the open and closed states thereof by changing a shape thereof.
20. The apparatus according to claim 5, wherein the valve member is configured to be biased toward being in the closed state thereof.
21. The apparatus according to any one of claims 1-4, wherein, in the compressed configuration, the prosthetic valve has a greatest transverse diameter of less than 12 mm.
22. The apparatus according to claim 21, wherein, in the compressed configuration, the prosthetic valve has a greatest transverse diameter of less than 9 mm.
23. The apparatus according to claim 22, wherein, in the compressed configuration, the prosthetic valve has a greatest transverse diameter of less than 6 mm.
24. The apparatus according to any one of claims 1-4, wherein the prosthetic valve is intracorporeally expandable from the compressed configuration to the expanded configuration.
25. The apparatus according to claim 24, wherein the prosthetic valve is configured to be percutaneously delivered in the constrained configuration thereof, by being restrained in the compressed configuration during the percutaneous delivery, and wherein the prosthetic valve is configured to automatically expand toward the expanded configuration thereof when no longer restrained.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/442,541 US9498332B2 (en) | 2012-11-13 | 2013-11-13 | Percutaneously-deliverable mechanical valve |
US15/354,504 US10045845B2 (en) | 2012-11-13 | 2016-11-17 | Percutaneously-deliverable mechanical valve |
US16/100,718 US10500040B2 (en) | 2012-11-13 | 2018-08-10 | Percutaneously-deliverable dual-frame valve |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/675,119 US8628571B1 (en) | 2012-11-13 | 2012-11-13 | Percutaneously-deliverable mechanical valve |
US13/675,119 | 2012-11-13 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/675,119 Continuation US8628571B1 (en) | 2012-11-13 | 2012-11-13 | Percutaneously-deliverable mechanical valve |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/442,541 A-371-Of-International US9498332B2 (en) | 2012-11-13 | 2013-11-13 | Percutaneously-deliverable mechanical valve |
US15/354,504 Continuation US10045845B2 (en) | 2012-11-13 | 2016-11-17 | Percutaneously-deliverable mechanical valve |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014076696A1 true WO2014076696A1 (en) | 2014-05-22 |
Family
ID=49886038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2013/050937 WO2014076696A1 (en) | 2012-11-13 | 2013-11-13 | Percutaneously-deliverable mechanical valve |
Country Status (2)
Country | Link |
---|---|
US (4) | US8628571B1 (en) |
WO (1) | WO2014076696A1 (en) |
Cited By (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9498332B2 (en) | 2012-11-13 | 2016-11-22 | Mitraltech Ltd. | Percutaneously-deliverable mechanical valve |
US9622861B2 (en) | 2009-12-02 | 2017-04-18 | Valtech Cardio, Ltd. | Tool for actuating an adjusting mechanism |
US9724192B2 (en) | 2011-11-08 | 2017-08-08 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
US9730793B2 (en) | 2012-12-06 | 2017-08-15 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
US9775709B2 (en) | 2011-11-04 | 2017-10-03 | Valtech Cardio, Ltd. | Implant having multiple adjustable mechanisms |
US9872769B2 (en) | 2006-12-05 | 2018-01-23 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US9883943B2 (en) | 2006-12-05 | 2018-02-06 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US9937042B2 (en) | 2009-05-07 | 2018-04-10 | Valtech Cardio, Ltd. | Multiple anchor delivery tool |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
US9968454B2 (en) | 2009-10-29 | 2018-05-15 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of artificial chordae |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
DE102017106792A1 (en) | 2017-03-29 | 2018-10-04 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin | Heart valve prosthesis |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
USD841812S1 (en) | 2017-08-03 | 2019-02-26 | Cardiovalve Ltd. | Prosthetic heart valve element |
US10231831B2 (en) | 2009-12-08 | 2019-03-19 | Cardiovalve Ltd. | Folding ring implant for heart valve |
US10265170B2 (en) | 2013-12-26 | 2019-04-23 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
US10350068B2 (en) | 2009-02-17 | 2019-07-16 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
US10376361B2 (en) | 2011-08-05 | 2019-08-13 | Cardiovalve Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US10390952B2 (en) | 2015-02-05 | 2019-08-27 | Cardiovalve Ltd. | Prosthetic valve with flexible tissue anchor portions |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
US10492908B2 (en) | 2014-07-30 | 2019-12-03 | Cardiovalve Ltd. | Anchoring of a prosthetic valve |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US10548729B2 (en) | 2009-05-04 | 2020-02-04 | Valtech Cardio, Ltd. | Deployment techniques for annuloplasty ring and over-wire rotation tool |
US10561498B2 (en) | 2005-03-17 | 2020-02-18 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US10631982B2 (en) | 2013-01-24 | 2020-04-28 | Cardiovale Ltd. | Prosthetic valve and upstream support therefor |
US10702385B2 (en) | 2011-08-05 | 2020-07-07 | Cardiovalve Ltd. | Implant for heart valve |
US10856975B2 (en) | 2016-08-10 | 2020-12-08 | Cardiovalve Ltd. | Prosthetic valve with concentric frames |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US10952850B2 (en) | 2016-08-01 | 2021-03-23 | Cardiovalve Ltd. | Minimally-invasive delivery systems |
US11026792B2 (en) | 2018-09-17 | 2021-06-08 | Cardiovalve Ltd. | Leaflet-grouping system |
US11065122B2 (en) | 2017-10-19 | 2021-07-20 | Cardiovalve Ltd. | Techniques for use with prosthetic valve leaflets |
US11109964B2 (en) | 2010-03-10 | 2021-09-07 | Cardiovalve Ltd. | Axially-shortening prosthetic valve |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US11291545B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Implant for heart valve |
US11298117B2 (en) | 2016-02-16 | 2022-04-12 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US11382746B2 (en) | 2017-12-13 | 2022-07-12 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
US11426155B2 (en) | 2010-07-21 | 2022-08-30 | Cardiovalve Ltd. | Helical anchor implantation |
US11633277B2 (en) | 2018-01-10 | 2023-04-25 | Cardiovalve Ltd. | Temperature-control during crimping of an implant |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
Families Citing this family (128)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004324043A1 (en) | 2004-10-02 | 2006-04-20 | Christoph Hans Huber | Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
EP2219558B8 (en) | 2007-08-21 | 2015-09-23 | Symetis SA | Stent-valves for valve replacement and associated systems for surgery |
EP3311779A1 (en) | 2007-10-25 | 2018-04-25 | Symetis SA | Stents, valved-stents and methods and systems for delivery thereof |
WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
EP2367505B1 (en) | 2008-09-29 | 2020-08-12 | Edwards Lifesciences CardiAQ LLC | Heart valve |
CN102341063B (en) | 2008-12-22 | 2015-11-25 | 瓦尔泰克卡迪欧有限公司 | Adjustable annuloplasty device and governor motion thereof |
US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
CA2961053C (en) | 2009-04-15 | 2019-04-30 | Edwards Lifesciences Cardiaq Llc | Vascular implant and delivery system |
US20110313515A1 (en) | 2010-06-21 | 2011-12-22 | Arshad Quadri | Replacement heart valve |
US10376359B2 (en) * | 2009-11-02 | 2019-08-13 | Symetis Sa | Aortic bioprosthesis and systems for delivery thereof |
US9307980B2 (en) | 2010-01-22 | 2016-04-12 | 4Tech Inc. | Tricuspid valve repair using tension |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
US8961596B2 (en) | 2010-01-22 | 2015-02-24 | 4Tech Inc. | Method and apparatus for tricuspid valve repair using tension |
US8475525B2 (en) | 2010-01-22 | 2013-07-02 | 4Tech Inc. | Tricuspid valve repair using tension |
US9241702B2 (en) | 2010-01-22 | 2016-01-26 | 4Tech Inc. | Method and apparatus for tricuspid valve repair using tension |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
US9132009B2 (en) | 2010-07-21 | 2015-09-15 | Mitraltech Ltd. | Guide wires with commissural anchors to advance a prosthetic valve |
US8992604B2 (en) | 2010-07-21 | 2015-03-31 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US20130274873A1 (en) | 2012-03-22 | 2013-10-17 | Symetis Sa | Transcatheter Stent-Valves and Methods, Systems and Devices for Addressing Para-Valve Leakage |
US11207176B2 (en) | 2012-03-22 | 2021-12-28 | Boston Scientific Scimed, Inc. | Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage |
US9011515B2 (en) * | 2012-04-19 | 2015-04-21 | Caisson Interventional, LLC | Heart valve assembly systems and methods |
US9427315B2 (en) | 2012-04-19 | 2016-08-30 | Caisson Interventional, LLC | Valve replacement systems and methods |
US8961594B2 (en) | 2012-05-31 | 2015-02-24 | 4Tech Inc. | Heart valve repair system |
EP2900150B1 (en) | 2012-09-29 | 2018-04-18 | Mitralign, Inc. | Plication lock delivery system |
WO2014064695A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
US9949828B2 (en) | 2012-10-23 | 2018-04-24 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
EP2943132B1 (en) | 2013-01-09 | 2018-03-28 | 4Tech Inc. | Soft tissue anchors |
US9724084B2 (en) | 2013-02-26 | 2017-08-08 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
WO2014141239A1 (en) | 2013-03-14 | 2014-09-18 | 4Tech Inc. | Stent with tether interface |
US20140277427A1 (en) | 2013-03-14 | 2014-09-18 | Cardiaq Valve Technologies, Inc. | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
US9730791B2 (en) | 2013-03-14 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
EP2968847B1 (en) | 2013-03-15 | 2023-03-08 | Edwards Lifesciences Corporation | Translation catheter systems |
CN105491978A (en) | 2013-08-30 | 2016-04-13 | 耶拿阀门科技股份有限公司 | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
USD730520S1 (en) * | 2013-09-04 | 2015-05-26 | St. Jude Medical, Cardiology Division, Inc. | Stent with commissure attachments |
USD730521S1 (en) * | 2013-09-04 | 2015-05-26 | St. Jude Medical, Cardiology Division, Inc. | Stent with commissure attachments |
US9421094B2 (en) | 2013-10-23 | 2016-08-23 | Caisson Interventional, LLC | Methods and systems for heart valve therapy |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
US10039643B2 (en) | 2013-10-30 | 2018-08-07 | 4Tech Inc. | Multiple anchoring-point tension system |
WO2015127283A1 (en) | 2014-02-21 | 2015-08-27 | Cardiaq Valve Technologies, Inc. | Delivery device for controlled deployement of a replacement valve |
EP2921140A1 (en) | 2014-03-18 | 2015-09-23 | St. Jude Medical, Cardiology Division, Inc. | Percutaneous valve anchoring for a prosthetic aortic valve |
WO2015179423A1 (en) | 2014-05-19 | 2015-11-26 | Cardiaq Valve Technologies, Inc. | Replacement mitral valve with annular flap |
US9532870B2 (en) | 2014-06-06 | 2017-01-03 | Edwards Lifesciences Corporation | Prosthetic valve for replacing a mitral valve |
US9974647B2 (en) | 2014-06-12 | 2018-05-22 | Caisson Interventional, LLC | Two stage anchor and mitral valve assembly |
CN106573129B (en) | 2014-06-19 | 2019-09-24 | 4科技有限公司 | Heart tissue is tightened |
EP3206629B1 (en) | 2014-10-14 | 2021-07-14 | Valtech Cardio, Ltd. | Apparatus for heart valve leaflet restraining |
US9750605B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
US9750607B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
US9907547B2 (en) | 2014-12-02 | 2018-03-06 | 4Tech Inc. | Off-center tissue anchors |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
CN107613908B (en) | 2015-03-19 | 2020-03-10 | 凯森因特万逊奈尔有限公司 | Systems and methods for heart valve therapy |
US10441416B2 (en) | 2015-04-21 | 2019-10-15 | Edwards Lifesciences Corporation | Percutaneous mitral valve replacement device |
CN114515173A (en) | 2015-04-30 | 2022-05-20 | 瓦尔泰克卡迪欧有限公司 | Valvuloplasty techniques |
US10376363B2 (en) | 2015-04-30 | 2019-08-13 | Edwards Lifesciences Cardiaq Llc | Replacement mitral valve, delivery system for replacement mitral valve and methods of use |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
WO2016183526A1 (en) | 2015-05-14 | 2016-11-17 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CA2990872C (en) | 2015-06-22 | 2022-03-22 | Edwards Lifescience Cardiaq Llc | Actively controllable heart valve implant and methods of controlling same |
US10092400B2 (en) | 2015-06-23 | 2018-10-09 | Edwards Lifesciences Cardiaq Llc | Systems and methods for anchoring and sealing a prosthetic heart valve |
US10575951B2 (en) | 2015-08-26 | 2020-03-03 | Edwards Lifesciences Cardiaq Llc | Delivery device and methods of use for transapical delivery of replacement mitral valve |
US10117744B2 (en) | 2015-08-26 | 2018-11-06 | Edwards Lifesciences Cardiaq Llc | Replacement heart valves and methods of delivery |
US10350066B2 (en) | 2015-08-28 | 2019-07-16 | Edwards Lifesciences Cardiaq Llc | Steerable delivery system for replacement mitral valve and methods of use |
US10478288B2 (en) | 2015-09-30 | 2019-11-19 | Clover Life Sciences Inc. | Trileaflet mechanical prosthetic heart valve |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
EP3960127A1 (en) | 2015-12-30 | 2022-03-02 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
WO2017117370A2 (en) | 2015-12-30 | 2017-07-06 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
USD815744S1 (en) | 2016-04-28 | 2018-04-17 | Edwards Lifesciences Cardiaq Llc | Valve frame for a delivery system |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
WO2017202766A2 (en) * | 2016-05-24 | 2017-11-30 | Cardiomech As | Flexible implants and method of use |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
US10350062B2 (en) | 2016-07-21 | 2019-07-16 | Edwards Lifesciences Corporation | Replacement heart valve prosthesis |
USD800908S1 (en) | 2016-08-10 | 2017-10-24 | Mitraltech Ltd. | Prosthetic valve element |
WO2018035375A1 (en) | 2016-08-19 | 2018-02-22 | Edwards Lifesciences Corporation | Steerable delivery system for replacement mitral valve and methods of use |
DK3503848T3 (en) | 2016-08-26 | 2021-11-15 | Edwards Lifesciences Corp | Replacement heart valve prosthesis in several parts |
US10758348B2 (en) | 2016-11-02 | 2020-09-01 | Edwards Lifesciences Corporation | Supra and sub-annular mitral valve delivery system |
FR3058631B1 (en) * | 2016-11-14 | 2019-01-25 | Laboratoires Invalv | IMPLANT FOR TREATING A BIOLOGICAL VALVE |
CR20190381A (en) | 2017-01-23 | 2019-09-27 | Cephea Valve Tech Inc | Replacement mitral valves |
AU2018203053B2 (en) | 2017-01-23 | 2020-03-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
WO2018158635A1 (en) * | 2017-02-28 | 2018-09-07 | Besselink Petrus A | Stented valve |
CN110678149B (en) | 2017-03-27 | 2021-12-21 | 楚利福医疗有限公司 | Device for treating a diseased mitral valve comprising a docking element |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
US10813757B2 (en) | 2017-07-06 | 2020-10-27 | Edwards Lifesciences Corporation | Steerable rail delivery system |
US11666444B2 (en) | 2017-08-03 | 2023-06-06 | The Regents Of The University Of California | Atrial cage for placement, securing and anchoring of atrioventricular valves |
US10856972B2 (en) | 2017-09-19 | 2020-12-08 | Cardiovalve Ltd. | Prosthetic valve with angularly offset atrial anchoring arms and ventricular anchoring legs |
WO2019079788A1 (en) | 2017-10-20 | 2019-04-25 | Boston Scientific Scimed, Inc. | Heart valve repair implant for treating tricuspid regurgitation |
JP7202374B2 (en) * | 2017-10-31 | 2023-01-11 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | valved conduit |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
WO2019145947A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
EP3720390A2 (en) | 2018-01-25 | 2020-10-14 | Edwards Lifesciences Corporation | Delivery system for aided replacement valve recapture and repositioning post- deployment |
EP3743014B1 (en) | 2018-01-26 | 2023-07-19 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
EP3752098A1 (en) * | 2018-02-15 | 2020-12-23 | Tricares SAS | Stent and replacement heart valve prosthesis with improved fixation features |
US11051934B2 (en) | 2018-02-28 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic mitral valve with improved anchors and seal |
WO2019195860A2 (en) | 2018-04-04 | 2019-10-10 | Vdyne, Llc | Devices and methods for anchoring transcatheter heart valve |
EP4295820A3 (en) * | 2018-07-06 | 2024-02-28 | Allurion Technologies, Inc. | Binary fluid control valve system |
AU2019301967A1 (en) | 2018-07-12 | 2021-01-21 | Edwards Lifesciences Innovation (Israel) Ltd. | Annuloplasty systems and locking tools therefor |
US11278437B2 (en) | 2018-12-08 | 2022-03-22 | Vdyne, Inc. | Compression capable annular frames for side delivery of transcatheter heart valve replacement |
US11071627B2 (en) | 2018-10-18 | 2021-07-27 | Vdyne, Inc. | Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis |
US10321995B1 (en) | 2018-09-20 | 2019-06-18 | Vdyne, Llc | Orthogonally delivered transcatheter heart valve replacement |
US11344413B2 (en) | 2018-09-20 | 2022-05-31 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
US11395738B2 (en) | 2018-09-25 | 2022-07-26 | Truleaf Medical Ltd. | Docking elements |
US11109969B2 (en) * | 2018-10-22 | 2021-09-07 | Vdyne, Inc. | Guidewire delivery of transcatheter heart valve |
US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
US11185409B2 (en) | 2019-01-26 | 2021-11-30 | Vdyne, Inc. | Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis |
US11273032B2 (en) * | 2019-01-26 | 2022-03-15 | Vdyne, Inc. | Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis |
WO2020181154A2 (en) * | 2019-03-05 | 2020-09-10 | Vdyne, Inc. | Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis |
US11076956B2 (en) | 2019-03-14 | 2021-08-03 | Vdyne, Inc. | Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis |
US11173027B2 (en) | 2019-03-14 | 2021-11-16 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
JP2022530764A (en) | 2019-05-04 | 2022-07-01 | ブイダイン,インコーポレイテッド | Tightening device and method for deploying a laterally delivered artificial heart valve with a native annulus. |
CA3152042A1 (en) | 2019-08-20 | 2021-02-25 | Vdyne, Inc. | Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves |
JP2022545728A (en) | 2019-08-26 | 2022-10-28 | ブイダイン,インコーポレイテッド | Transcatheter prosthetic valves capable of lateral delivery and methods for their delivery and fixation |
CR20210640A (en) | 2019-10-29 | 2022-05-30 | Valtech Cardio Ltd | Annuloplasty and tissue anchor technologies |
US11234813B2 (en) | 2020-01-17 | 2022-02-01 | Vdyne, Inc. | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery |
US11857417B2 (en) | 2020-08-16 | 2024-01-02 | Trilio Medical Ltd. | Leaflet support |
EP4271326A1 (en) * | 2021-02-11 | 2023-11-08 | Edwards Lifesciences Corporation | Prosthetic valves |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4423525A (en) * | 1981-07-14 | 1984-01-03 | Sorin Biomedica S.P.A. | Heart valve prosthesis |
US4853986A (en) * | 1986-01-02 | 1989-08-08 | The Awareness Marketing Corporation | Water level control |
US20020032481A1 (en) * | 2000-09-12 | 2002-03-14 | Shlomo Gabbay | Heart valve prosthesis and sutureless implantation of a heart valve prosthesis |
US7351256B2 (en) * | 2002-05-10 | 2008-04-01 | Cordis Corporation | Frame based unidirectional flow prosthetic implant |
US20110251678A1 (en) * | 2007-02-05 | 2011-10-13 | Boston Scientific Scimed, Inc. | Percutaneous Valve, System, and Method |
WO2012127309A1 (en) * | 2011-03-21 | 2012-09-27 | Ontorfano Matteo | Disk-based valve apparatus and method for the treatment of valve dysfunction |
US8628571B1 (en) * | 2012-11-13 | 2014-01-14 | Mitraltech Ltd. | Percutaneously-deliverable mechanical valve |
Family Cites Families (245)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4275469A (en) | 1979-12-13 | 1981-06-30 | Shelhigh Inc. | Prosthetic heart valve |
JPS6137235A (en) | 1984-07-31 | 1986-02-22 | テルモ株式会社 | Artificial valve |
CH678393A5 (en) | 1989-01-26 | 1991-09-13 | Ulrich Prof Dr Med Sigwart | |
US4994077A (en) | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
US5078739A (en) | 1990-07-20 | 1992-01-07 | Janus Biomedical, Inc. | Bileaflet heart valve with external leaflets |
US5397351A (en) | 1991-05-13 | 1995-03-14 | Pavcnik; Dusan | Prosthetic valve for percutaneous insertion |
FR2688401B1 (en) | 1992-03-12 | 1998-02-27 | Thierry Richard | EXPANDABLE STENT FOR HUMAN OR ANIMAL TUBULAR MEMBER, AND IMPLEMENTATION TOOL. |
US5332402A (en) | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
US5405378A (en) | 1992-05-20 | 1995-04-11 | Strecker; Ernst P. | Device with a prosthesis implantable in the body of a patient |
US5713950A (en) | 1993-11-01 | 1998-02-03 | Cox; James L. | Method of replacing heart valves using flexible tubes |
US6165210A (en) | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
US5824041A (en) | 1994-06-08 | 1998-10-20 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
US6015429A (en) | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US5765682A (en) | 1994-10-13 | 1998-06-16 | Menlo Care, Inc. | Restrictive package for expandable or shape memory medical devices and method of preventing premature change of same |
US5647857A (en) | 1995-03-16 | 1997-07-15 | Endotex Interventional Systems, Inc. | Protective intraluminal sheath |
US6010530A (en) | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
US6193745B1 (en) | 1995-10-03 | 2001-02-27 | Medtronic, Inc. | Modular intraluminal prosteheses construction and methods |
US6402780B2 (en) | 1996-02-23 | 2002-06-11 | Cardiovascular Technologies, L.L.C. | Means and method of replacing a heart valve in a minimally invasive manner |
JP3622020B2 (en) | 1996-07-31 | 2005-02-23 | ヤマハ発動機株式会社 | Battery box attachment / detachment structure for electric bicycle |
US6352561B1 (en) | 1996-12-23 | 2002-03-05 | W. L. Gore & Associates | Implant deployment apparatus |
US6551350B1 (en) | 1996-12-23 | 2003-04-22 | Gore Enterprise Holdings, Inc. | Kink resistant bifurcated prosthesis |
EP0850607A1 (en) | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
US5980565A (en) | 1997-10-20 | 1999-11-09 | Iowa-India Investments Company Limited | Sandwich stent |
US6059827A (en) | 1998-05-04 | 2000-05-09 | Axya Medical, Inc. | Sutureless cardiac valve prosthesis, and devices and methods for implanting them |
US6334873B1 (en) | 1998-09-28 | 2002-01-01 | Autogenics | Heart valve having tissue retention with anchors and an outer sheath |
EP1095635A4 (en) | 1999-05-06 | 2007-06-20 | Kanji Inoue | Apparatus for folding instrument and use of the same apparatus |
US6790229B1 (en) | 1999-05-25 | 2004-09-14 | Eric Berreklouw | Fixing device, in particular for fixing to vascular wall tissue |
US6287339B1 (en) | 1999-05-27 | 2001-09-11 | Sulzer Carbomedics Inc. | Sutureless heart valve prosthesis |
US6312465B1 (en) | 1999-07-23 | 2001-11-06 | Sulzer Carbomedics Inc. | Heart valve prosthesis with a resiliently deformable retaining member |
US6533806B1 (en) | 1999-10-01 | 2003-03-18 | Scimed Life Systems, Inc. | Balloon yielded delivery system and endovascular graft design for easy deployment |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US6458153B1 (en) | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US6454799B1 (en) | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
SE522805C2 (en) | 2000-06-22 | 2004-03-09 | Jan Otto Solem | Stent Application System |
US7381220B2 (en) | 2000-09-20 | 2008-06-03 | Ample Medical, Inc. | Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet |
US6482228B1 (en) | 2000-11-14 | 2002-11-19 | Troy R. Norred | Percutaneous aortic valve replacement |
US6974476B2 (en) | 2003-05-05 | 2005-12-13 | Rex Medical, L.P. | Percutaneous aortic valve |
US20050182483A1 (en) | 2004-02-11 | 2005-08-18 | Cook Incorporated | Percutaneously placed prosthesis with thromboresistant valve portion |
US6733525B2 (en) | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US20050148925A1 (en) | 2001-04-20 | 2005-07-07 | Dan Rottenberg | Device and method for controlling in-vivo pressure |
KR100393548B1 (en) | 2001-06-05 | 2003-08-02 | 주식회사 엠아이텍 | Stent |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
DE10148185B4 (en) | 2001-09-28 | 2005-08-11 | Alveolus, Inc. | Instrument for implanting vascular prostheses |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
WO2003094795A1 (en) | 2002-05-10 | 2003-11-20 | Cordis Corporation | Method of making a medical device having a thin wall tubular membrane over a structural frame |
US6984242B2 (en) | 2002-12-20 | 2006-01-10 | Gore Enterprise Holdings, Inc. | Implantable medical device assembly |
US7753945B2 (en) | 2003-01-17 | 2010-07-13 | Gore Enterprise Holdings, Inc. | Deployment system for an endoluminal device |
US7175656B2 (en) | 2003-04-18 | 2007-02-13 | Alexander Khairkhahan | Percutaneous transcatheter heart valve replacement |
US20040260394A1 (en) | 2003-06-20 | 2004-12-23 | Medtronic Vascular, Inc. | Cardiac valve annulus compressor system |
RU2006103367A (en) | 2003-07-08 | 2006-06-27 | Вентор Текнолоджиз Лтд. (Il) | IMPLANTED PROSTHETIC DEVICES, IN PARTICULAR, FOR TRANSARTHERIAL DELIVERY IN TREATMENT OF AORTAL STENOSIS AND METHODS OF IMPLANTING SUCH DEVICES |
US7201772B2 (en) | 2003-07-08 | 2007-04-10 | Ventor Technologies, Ltd. | Fluid flow prosthetic device |
NZ527025A (en) | 2003-07-16 | 2007-01-26 | David Peter Shaw | Prosthetic valves for medical application |
WO2005009285A2 (en) | 2003-07-21 | 2005-02-03 | The Trustees Of The University Of Pennsylvania | Percutaneous heart valve |
US8784472B2 (en) | 2003-08-15 | 2014-07-22 | Boston Scientific Scimed, Inc. | Clutch driven stent delivery system |
DE602004017750D1 (en) | 2003-08-19 | 2008-12-24 | Nmt Medical Inc | Expandable lock hose |
US10219899B2 (en) | 2004-04-23 | 2019-03-05 | Medtronic 3F Therapeutics, Inc. | Cardiac valve replacement systems |
US20050075713A1 (en) | 2003-10-06 | 2005-04-07 | Brian Biancucci | Minimally invasive valve replacement system |
US20060259137A1 (en) | 2003-10-06 | 2006-11-16 | Jason Artof | Minimally invasive valve replacement system |
US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US9254213B2 (en) | 2004-01-09 | 2016-02-09 | Rubicon Medical, Inc. | Stent delivery device |
JP4975609B2 (en) | 2004-02-27 | 2012-07-11 | エーオーテックス, インコーポレイテッド | Prosthetic heart valve delivery system and method |
WO2005087140A1 (en) | 2004-03-11 | 2005-09-22 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
US7942927B2 (en) | 2004-03-15 | 2011-05-17 | Baker Medical Research Institute | Treating valve failure |
US7374573B2 (en) | 2004-05-03 | 2008-05-20 | Shlomo Gabbay | System and method for improving ventricular function |
US8377118B2 (en) | 2004-05-05 | 2013-02-19 | Direct Flow Medical, Inc. | Unstented heart valve with formed in place support structure |
EP1768630B1 (en) | 2004-06-16 | 2015-01-07 | Machine Solutions, Inc. | Stent crimping device |
US8308789B2 (en) | 2004-07-16 | 2012-11-13 | W. L. Gore & Associates, Inc. | Deployment system for intraluminal devices |
US7347868B2 (en) | 2004-10-26 | 2008-03-25 | Baronova, Inc. | Medical device delivery catheter |
WO2006050460A1 (en) | 2004-10-29 | 2006-05-11 | Cook Incorporated | Vascular valves having implanted and target configurations and methods of preparing the same |
WO2006064490A1 (en) | 2004-12-15 | 2006-06-22 | Mednua Limited | A medical device suitable for use in treatment of a valve |
TW200633810A (en) | 2004-12-28 | 2006-10-01 | Arakawa Chem Ind | Lead-free solder flux and solder paste |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
WO2006089236A1 (en) | 2005-02-18 | 2006-08-24 | The Cleveland Clinic Foundation | Apparatus and methods for replacing a cardiac valve |
US20070213810A1 (en) | 2005-03-14 | 2007-09-13 | Richard Newhauser | Segmented endoprosthesis |
FR2885794B1 (en) | 2005-05-19 | 2007-08-17 | Perouse Soc Par Actions Simpli | NECESSARY FOR LANDING A CAVITY TREATMENT BODY AND METHOD FOR PREPARING A TREATMENT BODY THEREFOR |
EP3072475B1 (en) | 2005-05-27 | 2018-10-03 | HLT, Inc. | Stentless support structure |
US8968379B2 (en) | 2005-09-02 | 2015-03-03 | Medtronic Vascular, Inc. | Stent delivery system with multiple evenly spaced pullwires |
US7530253B2 (en) | 2005-09-09 | 2009-05-12 | Edwards Lifesciences Corporation | Prosthetic valve crimping device |
DE102005052628B4 (en) | 2005-11-04 | 2014-06-05 | Jenavalve Technology Inc. | Self-expanding, flexible wire mesh with integrated valvular prosthesis for the transvascular heart valve replacement and a system with such a device and a delivery catheter |
US8764820B2 (en) | 2005-11-16 | 2014-07-01 | Edwards Lifesciences Corporation | Transapical heart valve delivery system and method |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US9375215B2 (en) | 2006-01-20 | 2016-06-28 | W. L. Gore & Associates, Inc. | Device for rapid repair of body conduits |
EP1991168B1 (en) | 2006-02-16 | 2016-01-27 | Transcatheter Technologies GmbH | Minimally invasive heart valve replacement |
US7625403B2 (en) | 2006-04-04 | 2009-12-01 | Medtronic Vascular, Inc. | Valved conduit designed for subsequent catheter delivered valve therapy |
US8551161B2 (en) | 2006-04-25 | 2013-10-08 | Medtronic Vascular, Inc. | Cardiac valve annulus restraining device |
US8070800B2 (en) | 2006-05-05 | 2011-12-06 | Children's Medical Center Corporation | Transcatheter heart valve prostheses |
MX2009000978A (en) | 2006-07-26 | 2009-02-06 | Menicon Co Ltd | Systems and methods for providing contact lenses to consumers. |
WO2008013915A2 (en) | 2006-07-28 | 2008-01-31 | Arshad Quadri | Percutaneous valve prosthesis and system and method for implanting same |
US20080097595A1 (en) | 2006-08-22 | 2008-04-24 | Shlomo Gabbay | Intraventricular cardiac prosthesis |
FR2906454B1 (en) | 2006-09-28 | 2009-04-10 | Perouse Soc Par Actions Simpli | IMPLANT INTENDED TO BE PLACED IN A BLOOD CIRCULATION CONDUIT. |
WO2008042311A1 (en) | 2006-09-28 | 2008-04-10 | Nmt Medical. Inc. | Perforated expandable implant recovery sheath |
US20090248143A1 (en) | 2006-10-24 | 2009-10-01 | Beth Israel Deaconess Medical Center | Percutaneous aortic valve assembly |
US20080140003A1 (en) | 2006-12-06 | 2008-06-12 | Advanced Cardiovascular Systems, Inc. | Balloon catheter having a regrooming sheath and method for collapsing an expanded medical device |
JP5593545B2 (en) | 2006-12-06 | 2014-09-24 | メドトロニック シーブイ ルクセンブルク エス.アー.エール.エル. | System and method for transapical delivery of a self-expanding valve secured to an annulus |
US8070799B2 (en) | 2006-12-19 | 2011-12-06 | Sorin Biomedica Cardio S.R.L. | Instrument and method for in situ deployment of cardiac valve prostheses |
US8236045B2 (en) | 2006-12-22 | 2012-08-07 | Edwards Lifesciences Corporation | Implantable prosthetic valve assembly and method of making the same |
US20080167705A1 (en) | 2007-01-10 | 2008-07-10 | Cook Incorporated | Short wire stent delivery system with splittable outer sheath |
US8070802B2 (en) | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
WO2008121380A1 (en) | 2007-03-31 | 2008-10-09 | Cook Incorporated | Medical device delivery system with sheath separation |
US8273115B2 (en) | 2007-04-24 | 2012-09-25 | W. L. Gore & Associates, Inc. | Side branched endoluminal prostheses and methods of delivery thereof |
US7667351B2 (en) | 2007-04-27 | 2010-02-23 | Liebert Corporation | Method for pulse width modulation synchronization in a parallel UPS system |
EP2146669B1 (en) | 2007-05-11 | 2014-07-30 | Cook Medical Technologies LLC | Stent grafts for the thoracic aorta |
US20090112159A1 (en) | 2007-10-31 | 2009-04-30 | David Slattery | Delivery System With Profiled Sheath Having Balloon-Oriented Position |
EP2160150B1 (en) | 2007-06-26 | 2011-10-26 | St. Jude Medical, Inc. | Apparatus for implanting collapsible/expandable prosthetic heart valves |
US9566178B2 (en) | 2010-06-24 | 2017-02-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US9814611B2 (en) | 2007-07-31 | 2017-11-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
DE102007043830A1 (en) | 2007-09-13 | 2009-04-02 | Lozonschi, Lucian, Madison | Heart valve stent |
WO2009045334A1 (en) | 2007-09-28 | 2009-04-09 | St. Jude Medical, Inc. | Collapsible/expandable prosthetic heart valves with native calcified leaflet retention features |
WO2009045331A1 (en) | 2007-09-28 | 2009-04-09 | St. Jude Medical, Inc. | Two-stage collapsible/expandable prosthetic heart valves and anchoring systems |
US7981151B2 (en) | 2007-10-15 | 2011-07-19 | Edwards Lifesciences Corporation | Transcatheter heart valve with micro-anchors |
EP4079261A1 (en) | 2007-12-14 | 2022-10-26 | Edwards Lifesciences Corporation | Leaflet attachment frame for a prosthetic valve |
EP2072027B1 (en) | 2007-12-21 | 2020-06-17 | Medtentia International Ltd Oy | pre-annuloplasty device and method |
EP2240121B1 (en) | 2008-01-16 | 2019-05-22 | St. Jude Medical, Inc. | Delivery and retrieval systems for collapsible/expandable prosthetic heart valves |
WO2009094373A1 (en) | 2008-01-22 | 2009-07-30 | Cook Incorporated | Valve frame |
WO2009122299A2 (en) | 2008-04-03 | 2009-10-08 | Gardia Medical Ltd. | Delivery catheter with constraining sheath and methods of deploying medical devices into a body lumen |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
EP2291123A2 (en) | 2008-05-12 | 2011-03-09 | John T.M. Wright | Device and method for the surgical treatment of ischemic mitral regurgitation |
WO2010006627A1 (en) | 2008-07-17 | 2010-01-21 | Nvt Ag | Cardiac valve prosthesis system |
CN102245129B (en) | 2008-07-21 | 2015-03-18 | 詹妮弗·K·怀特 | Repositionable endoluminal support structure and its applications |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US9314335B2 (en) | 2008-09-19 | 2016-04-19 | Edwards Lifesciences Corporation | Prosthetic heart valve configured to receive a percutaneous prosthetic heart valve implantation |
EP2367505B1 (en) | 2008-09-29 | 2020-08-12 | Edwards Lifesciences CardiAQ LLC | Heart valve |
CA2739275C (en) | 2008-10-01 | 2017-01-17 | Impala, Inc. | Delivery system for vascular implant |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
US8308798B2 (en) | 2008-12-19 | 2012-11-13 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve and methods |
US8998982B2 (en) | 2009-01-12 | 2015-04-07 | Valve Medical Ltd. | Method and apparatus for fine adjustment of a percutaneous valve structure |
WO2010098857A1 (en) | 2009-02-27 | 2010-09-02 | St. Jude Medical, Inc. | Stent features for collapsible prosthetic heart valves |
US8021420B2 (en) | 2009-03-12 | 2011-09-20 | Medtronic Vascular, Inc. | Prosthetic valve delivery system |
CA2961053C (en) | 2009-04-15 | 2019-04-30 | Edwards Lifesciences Cardiaq Llc | Vascular implant and delivery system |
AU2010266210B2 (en) | 2009-07-02 | 2015-01-22 | The Cleveland Clinic Foundation | Apparatus and method for replacing a diseased cardiac valve |
US20110077730A1 (en) | 2009-09-30 | 2011-03-31 | Fenster Michael S | Bifurcated balloon stent |
US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
WO2011072084A2 (en) | 2009-12-08 | 2011-06-16 | Avalon Medical Ltd. | Device and system for transcatheter mitral valve replacement |
US9072603B2 (en) | 2010-02-24 | 2015-07-07 | Medtronic Ventor Technologies, Ltd. | Mitral prosthesis and methods for implantation |
WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US8408214B2 (en) | 2010-07-08 | 2013-04-02 | Benjamin Spenser | Method for implanting prosthetic valve |
US9326852B2 (en) | 2010-07-08 | 2016-05-03 | Benjamin Spenser | Method for implanting prosthetic valve |
US8657872B2 (en) | 2010-07-19 | 2014-02-25 | Jacques Seguin | Cardiac valve repair system and methods of use |
US9132009B2 (en) | 2010-07-21 | 2015-09-15 | Mitraltech Ltd. | Guide wires with commissural anchors to advance a prosthetic valve |
CA2808639A1 (en) | 2010-08-17 | 2012-02-23 | Palmaz Scientific, Inc. | Transluminal cardiac ball valve and method for deployment thereof |
US10105224B2 (en) | 2010-09-01 | 2018-10-23 | Mvalve Technologies Ltd. | Cardiac valve support structure |
EP2611391B1 (en) | 2010-09-01 | 2017-11-22 | Mvalve Technologies Ltd. | Cardiac valve support structure |
US10076327B2 (en) | 2010-09-14 | 2018-09-18 | Evalve, Inc. | Flexible actuator mandrel for tissue apposition systems |
WO2012040655A2 (en) | 2010-09-23 | 2012-03-29 | Cardiaq Valve Technologies, Inc. | Replacement heart valves, delivery devices and methods |
DE202011111128U1 (en) | 2010-10-05 | 2020-05-27 | Edwards Lifesciences Corporation | Prosthetic heart valve |
CN105380730B (en) | 2010-10-05 | 2018-08-17 | 爱德华兹生命科学公司 | Heart valve prosthesis |
US9468547B2 (en) | 2010-11-11 | 2016-10-18 | W. L. Gore & Associates, Inc. | Deployment of endoluminal devices |
US9414944B2 (en) | 2010-11-11 | 2016-08-16 | W. L. Gore & Associates, Inc. | Deployment sleeve shortening mechanism |
US20120130475A1 (en) | 2010-11-16 | 2012-05-24 | Shaw Edward E | Sleeves for expandable medical devices |
US9095466B2 (en) | 2010-11-16 | 2015-08-04 | W. L. Gore & Associates, Inc. | Apposition fiber for use in endoluminal deployment of expandable devices in tortuous anatomies |
US9675487B2 (en) | 2010-11-17 | 2017-06-13 | Cook Medical Technologies Llc | Prosthesis deployment system for vascular repair |
US8657866B2 (en) | 2010-12-22 | 2014-02-25 | Cook Medical Technologies Llc | Emergency vascular repair prosthesis deployment system |
CA2822381C (en) | 2010-12-23 | 2019-04-02 | Foundry Newco Xii, Inc. | System for mitral valve repair and replacement |
EP2478868A1 (en) | 2011-01-25 | 2012-07-25 | The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth | Implant device |
US8932343B2 (en) | 2011-02-01 | 2015-01-13 | St. Jude Medical, Cardiology Division, Inc. | Blunt ended stent for prosthetic heart valve |
US9021674B2 (en) | 2011-02-02 | 2015-05-05 | St. Jude Medical, Inc. | System for loading a collapsible heart valve |
US8876686B2 (en) | 2011-02-18 | 2014-11-04 | Vascor, Inc | Control of blood flow assist systems |
US9155619B2 (en) | 2011-02-25 | 2015-10-13 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9289282B2 (en) | 2011-05-31 | 2016-03-22 | Edwards Lifesciences Corporation | System and method for treating valve insufficiency or vessel dilatation |
US10117765B2 (en) | 2011-06-14 | 2018-11-06 | W.L. Gore Associates, Inc | Apposition fiber for use in endoluminal deployment of expandable implants |
CN107496054B (en) | 2011-06-21 | 2020-03-03 | 托尔福公司 | Prosthetic heart valve devices and related systems and methods |
US8920482B2 (en) | 2011-06-30 | 2014-12-30 | Cook Medical Technologies Llc | Stent delivery system |
CN103648445B (en) | 2011-07-12 | 2016-06-29 | 拉什大学医学中心 | There is the vessel bifurcation stent deployment system of zip mode conduit |
US20130018450A1 (en) | 2011-07-13 | 2013-01-17 | Hunt James B | Prosthesis delivery system with retention sleeve |
US8795357B2 (en) | 2011-07-15 | 2014-08-05 | Edwards Lifesciences Corporation | Perivalvular sealing for transcatheter heart valve |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US20130041451A1 (en) | 2011-08-09 | 2013-02-14 | Cook Medical Technologies Llc | Prosthesis deployment system for open surgical repair |
EP4289398A3 (en) | 2011-08-11 | 2024-03-13 | Tendyne Holdings, Inc. | Improvements for prosthetic valves and related inventions |
US20130331929A1 (en) | 2011-09-09 | 2013-12-12 | Endoluminal Sciences Pty Ltd. | Means for Controlled Sealing of Endovascular Devices |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
CN111000663B (en) | 2011-10-19 | 2022-04-15 | 托尔福公司 | Prosthetic heart valve devices, prosthetic mitral valves, and related systems and methods |
US9827093B2 (en) | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US9782282B2 (en) | 2011-11-14 | 2017-10-10 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9877858B2 (en) | 2011-11-14 | 2018-01-30 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9387097B2 (en) | 2011-11-16 | 2016-07-12 | W. L. Gore & Associates, Inc. | Implant assembly with tactile indicator |
AU2012344722A1 (en) | 2011-12-01 | 2014-06-26 | Graeme Cocks | Endoluminal prosthesis |
US9364359B2 (en) | 2011-12-08 | 2016-06-14 | W. L. Gore & Associates, Inc. | Systems and methods for delivery of a medical device |
CA3201836A1 (en) | 2011-12-09 | 2013-06-13 | Edwards Lifesciences Corporation | Prosthetic heart valve having improved commissure supports |
US9827092B2 (en) | 2011-12-16 | 2017-11-28 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
FR2985659B1 (en) | 2012-01-13 | 2015-03-06 | Assist Publ Hopitaux De Paris | DEVICE FOR ANCHORING A PROTHETIC CARDIAC VALVE. |
US9687371B2 (en) | 2012-02-14 | 2017-06-27 | W. L. Gore & Associates, Inc. | Endoprosthesis having aligned legs for ease of cannulation |
US20150094802A1 (en) | 2012-02-28 | 2015-04-02 | Mvalve Technologies Ltd. | Single-ring cardiac valve support |
US9375308B2 (en) | 2012-03-13 | 2016-06-28 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9066800B2 (en) | 2012-03-28 | 2015-06-30 | Medtronic, Inc. | Dual valve prosthesis for transcatheter valve implantation |
US8926694B2 (en) * | 2012-03-28 | 2015-01-06 | Medtronic Vascular Galway Limited | Dual valve prosthesis for transcatheter valve implantation |
US9277990B2 (en) | 2012-05-04 | 2016-03-08 | St. Jude Medical, Cardiology Division, Inc. | Hypotube shaft with articulation mechanism |
WO2013175468A2 (en) | 2012-05-20 | 2013-11-28 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Prosthetic mitral valve |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
DE102012010798A1 (en) | 2012-06-01 | 2013-12-05 | Universität Duisburg-Essen | Implantable device for improving or eliminating heart valve insufficiency |
CN104487026B (en) | 2012-07-12 | 2016-11-02 | 波士顿科学国际有限公司 | Little profile heart valve delivery system |
WO2014022124A1 (en) | 2012-07-28 | 2014-02-06 | Tendyne Holdings, Inc. | Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
US9486349B2 (en) | 2012-08-10 | 2016-11-08 | W. L. Gore & Associates, Inc. | Systems and methods of deployment of endoluminal devices |
US9232995B2 (en) | 2013-01-08 | 2016-01-12 | Medtronic, Inc. | Valve prosthesis and method for delivery |
US20140106951A1 (en) | 2012-10-15 | 2014-04-17 | W. L. Gore & Associates, Inc. | Methods and systems for securing a sleeve for endoluminal devices |
US10010654B2 (en) | 2012-10-30 | 2018-07-03 | W. L. Gore & Associates, Inc. | Sleeve for medical device assembly |
US9023099B2 (en) | 2012-10-31 | 2015-05-05 | Medtronic Vascular Galway Limited | Prosthetic mitral valve and delivery method |
US9610183B2 (en) | 2012-11-12 | 2017-04-04 | W.L. Gore & Associates, Inc. | Friction fiber sleeve retraction system |
US9387105B2 (en) | 2012-11-12 | 2016-07-12 | W.L. Gore & Associates, Inc | Sleeves for expandable medical devices and methods of making the same |
EP2745812B1 (en) | 2012-12-19 | 2017-01-18 | Cook Medical Technologies LLC | Repositionable diameter constraints |
EP3375411A1 (en) | 2012-12-31 | 2018-09-19 | Edwards Lifesciences Corporation | Surgical heart valves adapted for post-implant expansion |
EP2948103B1 (en) | 2013-01-24 | 2022-12-07 | Cardiovalve Ltd | Ventricularly-anchored prosthetic valves |
US9439763B2 (en) | 2013-02-04 | 2016-09-13 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
US10583002B2 (en) | 2013-03-11 | 2020-03-10 | Neovasc Tiara Inc. | Prosthetic valve with anti-pivoting mechanism |
US20140277358A1 (en) | 2013-03-13 | 2014-09-18 | DePuy Synthes Products, LLC | Striped stent introducer |
US20160030169A1 (en) | 2013-03-13 | 2016-02-04 | Aortic Innovations, Llc | Dual frame stent and valve devices and implantation |
US9681951B2 (en) | 2013-03-14 | 2017-06-20 | Edwards Lifesciences Cardiaq Llc | Prosthesis with outer skirt and anchors |
US9226839B1 (en) | 2013-03-14 | 2016-01-05 | W. L. Gore & Associates, Inc. | Torque sleeve |
US20140277427A1 (en) | 2013-03-14 | 2014-09-18 | Cardiaq Valve Technologies, Inc. | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
KR20220104302A (en) | 2013-03-15 | 2022-07-26 | 네비게이트 카디악 스트럭쳐스, 인크. | Catheter-guided replacement valves apparatus and methods |
US9232994B2 (en) | 2013-03-15 | 2016-01-12 | Medtronic Vascular Galway Limited | Stented prosthetic heart valve and methods for making |
US20140296969A1 (en) | 2013-04-02 | 2014-10-02 | Tendyne Holdlings, Inc. | Anterior Leaflet Clip Device for Prosthetic Mitral Valve |
CA2908342C (en) | 2013-05-20 | 2021-11-30 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
WO2014191994A1 (en) | 2013-05-29 | 2014-12-04 | Mvalve Technologies Ltd. | Cardiac valve support device fitted with valve leaflets |
US20140358224A1 (en) | 2013-05-30 | 2014-12-04 | Tendyne Holdlings, Inc. | Six cell inner stent device for prosthetic mitral valves |
US9788983B2 (en) | 2013-06-21 | 2017-10-17 | Abbott Cardiovascular Systems Inc. | Removable sheath assembly for a polymer scaffold |
US20140379076A1 (en) | 2013-06-25 | 2014-12-25 | Tendyne Holdings, Inc. | Halo Wire Fluid Seal Device for Prosthetic Mitral Valves |
US8870948B1 (en) | 2013-07-17 | 2014-10-28 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
US9421094B2 (en) | 2013-10-23 | 2016-08-23 | Caisson Interventional, LLC | Methods and systems for heart valve therapy |
JP2016538076A (en) | 2013-11-28 | 2016-12-08 | ムバルブ・テクノロジーズ・リミテッド | Intracardiac device comprising a stabilizing element with improved fatigue resistance |
US9072604B1 (en) | 2014-02-11 | 2015-07-07 | Gilberto Melnick | Modular transcatheter heart valve and implantation method |
USD755384S1 (en) | 2014-03-05 | 2016-05-03 | Edwards Lifesciences Cardiaq Llc | Stent |
AU2015229708B2 (en) | 2014-03-10 | 2019-08-15 | Tendyne Holdings, Inc. | Devices and methods for positioning and monitoring tether load for prosthetic mitral valve |
US10195025B2 (en) | 2014-05-12 | 2019-02-05 | Edwards Lifesciences Corporation | Prosthetic heart valve |
WO2015179423A1 (en) | 2014-05-19 | 2015-11-26 | Cardiaq Valve Technologies, Inc. | Replacement mitral valve with annular flap |
US9532870B2 (en) | 2014-06-06 | 2017-01-03 | Edwards Lifesciences Corporation | Prosthetic valve for replacing a mitral valve |
US9439757B2 (en) | 2014-12-09 | 2016-09-13 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
EP3253333B1 (en) | 2015-02-05 | 2024-04-03 | Cardiovalve Ltd | Prosthetic valve with axially-sliding frames |
US10441416B2 (en) | 2015-04-21 | 2019-10-15 | Edwards Lifesciences Corporation | Percutaneous mitral valve replacement device |
US10376363B2 (en) | 2015-04-30 | 2019-08-13 | Edwards Lifesciences Cardiaq Llc | Replacement mitral valve, delivery system for replacement mitral valve and methods of use |
WO2016183526A1 (en) | 2015-05-14 | 2016-11-17 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CA2990872C (en) | 2015-06-22 | 2022-03-22 | Edwards Lifescience Cardiaq Llc | Actively controllable heart valve implant and methods of controlling same |
US10092400B2 (en) | 2015-06-23 | 2018-10-09 | Edwards Lifesciences Cardiaq Llc | Systems and methods for anchoring and sealing a prosthetic heart valve |
US10117744B2 (en) | 2015-08-26 | 2018-11-06 | Edwards Lifesciences Cardiaq Llc | Replacement heart valves and methods of delivery |
CN114587712A (en) | 2016-08-10 | 2022-06-07 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with coaxial frame |
DK3503848T3 (en) | 2016-08-26 | 2021-11-15 | Edwards Lifesciences Corp | Replacement heart valve prosthesis in several parts |
-
2012
- 2012-11-13 US US13/675,119 patent/US8628571B1/en active Active
-
2013
- 2013-11-13 WO PCT/IL2013/050937 patent/WO2014076696A1/en active Application Filing
- 2013-11-13 US US14/442,541 patent/US9498332B2/en active Active
-
2016
- 2016-11-17 US US15/354,504 patent/US10045845B2/en active Active
-
2018
- 2018-08-10 US US16/100,718 patent/US10500040B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4423525A (en) * | 1981-07-14 | 1984-01-03 | Sorin Biomedica S.P.A. | Heart valve prosthesis |
US4853986A (en) * | 1986-01-02 | 1989-08-08 | The Awareness Marketing Corporation | Water level control |
US20020032481A1 (en) * | 2000-09-12 | 2002-03-14 | Shlomo Gabbay | Heart valve prosthesis and sutureless implantation of a heart valve prosthesis |
US7351256B2 (en) * | 2002-05-10 | 2008-04-01 | Cordis Corporation | Frame based unidirectional flow prosthetic implant |
US20110251678A1 (en) * | 2007-02-05 | 2011-10-13 | Boston Scientific Scimed, Inc. | Percutaneous Valve, System, and Method |
WO2012127309A1 (en) * | 2011-03-21 | 2012-09-27 | Ontorfano Matteo | Disk-based valve apparatus and method for the treatment of valve dysfunction |
US8628571B1 (en) * | 2012-11-13 | 2014-01-14 | Mitraltech Ltd. | Percutaneously-deliverable mechanical valve |
Cited By (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10561498B2 (en) | 2005-03-17 | 2020-02-18 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
US9974653B2 (en) | 2006-12-05 | 2018-05-22 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US9872769B2 (en) | 2006-12-05 | 2018-01-23 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US9883943B2 (en) | 2006-12-05 | 2018-02-06 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US10350068B2 (en) | 2009-02-17 | 2019-07-16 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
US10548729B2 (en) | 2009-05-04 | 2020-02-04 | Valtech Cardio, Ltd. | Deployment techniques for annuloplasty ring and over-wire rotation tool |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
US9937042B2 (en) | 2009-05-07 | 2018-04-10 | Valtech Cardio, Ltd. | Multiple anchor delivery tool |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9968454B2 (en) | 2009-10-29 | 2018-05-15 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of artificial chordae |
US9622861B2 (en) | 2009-12-02 | 2017-04-18 | Valtech Cardio, Ltd. | Tool for actuating an adjusting mechanism |
US10492909B2 (en) | 2009-12-02 | 2019-12-03 | Valtech Cardio, Ltd. | Tool for actuating an adjusting mechanism |
US11839541B2 (en) | 2009-12-08 | 2023-12-12 | Cardiovalve Ltd. | Prosthetic heart valve with upper skirt |
US11351026B2 (en) | 2009-12-08 | 2022-06-07 | Cardiovalve Ltd. | Rotation-based anchoring of an implant |
US10548726B2 (en) | 2009-12-08 | 2020-02-04 | Cardiovalve Ltd. | Rotation-based anchoring of an implant |
US11141268B2 (en) | 2009-12-08 | 2021-10-12 | Cardiovalve Ltd. | Prosthetic heart valve with upper and lower skirts |
US10231831B2 (en) | 2009-12-08 | 2019-03-19 | Cardiovalve Ltd. | Folding ring implant for heart valve |
US10660751B2 (en) | 2009-12-08 | 2020-05-26 | Cardiovalve Ltd. | Prosthetic heart valve with upper skirt |
US11109964B2 (en) | 2010-03-10 | 2021-09-07 | Cardiovalve Ltd. | Axially-shortening prosthetic valve |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US11426155B2 (en) | 2010-07-21 | 2022-08-30 | Cardiovalve Ltd. | Helical anchor implantation |
US11864995B2 (en) | 2011-08-05 | 2024-01-09 | Cardiovalve Ltd. | Implant for heart valve |
US11291545B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Implant for heart valve |
US11344410B2 (en) | 2011-08-05 | 2022-05-31 | Cardiovalve Ltd. | Implant for heart valve |
US11690712B2 (en) | 2011-08-05 | 2023-07-04 | Cardiovalve Ltd. | Clip-secured implant for heart valve |
US11291547B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Leaflet clip with collars |
US10702385B2 (en) | 2011-08-05 | 2020-07-07 | Cardiovalve Ltd. | Implant for heart valve |
US11291546B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Leaflet clip with collars |
US10695173B2 (en) | 2011-08-05 | 2020-06-30 | Cardiovalve Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US11517429B2 (en) | 2011-08-05 | 2022-12-06 | Cardiovalve Ltd. | Apparatus for use at a heart valve |
US11951005B2 (en) | 2011-08-05 | 2024-04-09 | Cardiovalve Ltd. | Implant for heart valve |
US11517436B2 (en) | 2011-08-05 | 2022-12-06 | Cardiovalve Ltd. | Implant for heart valve |
US11369469B2 (en) | 2011-08-05 | 2022-06-28 | Cardiovalve Ltd. | Method for use at a heart valve |
US10376361B2 (en) | 2011-08-05 | 2019-08-13 | Cardiovalve Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9775709B2 (en) | 2011-11-04 | 2017-10-03 | Valtech Cardio, Ltd. | Implant having multiple adjustable mechanisms |
US9724192B2 (en) | 2011-11-08 | 2017-08-08 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
US10045845B2 (en) | 2012-11-13 | 2018-08-14 | Mitraltech Ltd. | Percutaneously-deliverable mechanical valve |
US9498332B2 (en) | 2012-11-13 | 2016-11-22 | Mitraltech Ltd. | Percutaneously-deliverable mechanical valve |
US10500040B2 (en) | 2012-11-13 | 2019-12-10 | Cardiovalve Ltd. | Percutaneously-deliverable dual-frame valve |
US9730793B2 (en) | 2012-12-06 | 2017-08-15 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
US11844691B2 (en) | 2013-01-24 | 2023-12-19 | Cardiovalve Ltd. | Partially-covered prosthetic valves |
US10631982B2 (en) | 2013-01-24 | 2020-04-28 | Cardiovale Ltd. | Prosthetic valve and upstream support therefor |
US11135059B2 (en) | 2013-01-24 | 2021-10-05 | Cardiovalve Ltd. | Prosthetic valve and upstream support therefor |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
US10265170B2 (en) | 2013-12-26 | 2019-04-23 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US11701225B2 (en) | 2014-07-30 | 2023-07-18 | Cardiovalve Ltd. | Delivery of a prosthetic valve |
US10524910B2 (en) | 2014-07-30 | 2020-01-07 | Mitraltech Ltd. 3 Ariel Sharon Avenue | Articulatable prosthetic valve |
US11872130B2 (en) | 2014-07-30 | 2024-01-16 | Cardiovalve Ltd. | Prosthetic heart valve implant |
US10492908B2 (en) | 2014-07-30 | 2019-12-03 | Cardiovalve Ltd. | Anchoring of a prosthetic valve |
US10426610B2 (en) | 2015-02-05 | 2019-10-01 | Cardiovalve Ltd. | Prosthetic valve with radially-deflectable tissue anchors |
US11801135B2 (en) | 2015-02-05 | 2023-10-31 | Cardiovalve Ltd. | Techniques for deployment of a prosthetic valve |
US10864078B2 (en) | 2015-02-05 | 2020-12-15 | Cardiovalve Ltd. | Prosthetic valve with separably-deployable valve body and tissue anchors |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
US10888422B2 (en) | 2015-02-05 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic valve with flexible tissue anchor portions |
US10918481B2 (en) | 2015-02-05 | 2021-02-16 | Cardiovalve Ltd. | Techniques for deployment of a prosthetic valve |
US11672658B2 (en) | 2015-02-05 | 2023-06-13 | Cardiovalve Ltd. | Prosthetic valve with aligned inner and outer frames |
US10973636B2 (en) | 2015-02-05 | 2021-04-13 | Cardiovalve Ltd. | Prosthetic valve with tissue anchors free from lateral interconnections |
US11534298B2 (en) | 2015-02-05 | 2022-12-27 | Cardiovalve Ltd. | Prosthetic valve with s-shaped tissue anchors |
US10357360B2 (en) | 2015-02-05 | 2019-07-23 | Cardiovalve Ltd. | Prosthetic valve with aligned inner and outer frames |
US10849748B2 (en) | 2015-02-05 | 2020-12-01 | Cardiovalve Ltd. | Prosthetic valve delivery system with independently-movable capsule portions |
US10758344B2 (en) | 2015-02-05 | 2020-09-01 | Cardiovalve Ltd. | Prosthetic valve with angularly offset frames |
US10736742B2 (en) | 2015-02-05 | 2020-08-11 | Cardiovalve Ltd. | Prosthetic valve with atrial arms |
US10463487B2 (en) | 2015-02-05 | 2019-11-05 | Cardiovalve Ltd. | Prosthetic valve delivery system with independently-movable capsule portions |
US10722360B2 (en) | 2015-02-05 | 2020-07-28 | Cardiovalve Ltd. | Prosthetic valve with radially-deflectable tissue anchors |
US10695177B2 (en) | 2015-02-05 | 2020-06-30 | Cardiovalve Ltd. | Prosthetic valve with aligned inner and outer frames |
US10682227B2 (en) | 2015-02-05 | 2020-06-16 | Cardiovalve Ltd. | Prosthetic valve with pivoting tissue anchor portions |
US10463488B2 (en) | 2015-02-05 | 2019-11-05 | Cardiovalve Ltd. | Prosthetic valve with separably-deployable valve body and tissue anchors |
US10667908B2 (en) | 2015-02-05 | 2020-06-02 | Cardiovalve Ltd. | Prosthetic valve with S-shaped tissue anchors |
US11793635B2 (en) | 2015-02-05 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic valve with angularly offset frames |
US11793638B2 (en) | 2015-02-05 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic valve with pivoting tissue anchor portions |
US10390952B2 (en) | 2015-02-05 | 2019-08-27 | Cardiovalve Ltd. | Prosthetic valve with flexible tissue anchor portions |
US10524903B2 (en) | 2015-02-05 | 2020-01-07 | Cardiovalve Ltd. | Prosthetic valve with aligned inner and outer frames |
US10449047B2 (en) | 2015-02-05 | 2019-10-22 | Cardiovalve Ltd. | Prosthetic heart valve with compressible frames |
US10507105B2 (en) | 2015-02-05 | 2019-12-17 | Cardiovalve Ltd. | Prosthetic valve with tissue anchors free from lateral interconnections |
US11298117B2 (en) | 2016-02-16 | 2022-04-12 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US11937795B2 (en) | 2016-02-16 | 2024-03-26 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US10952850B2 (en) | 2016-08-01 | 2021-03-23 | Cardiovalve Ltd. | Minimally-invasive delivery systems |
US11779458B2 (en) | 2016-08-10 | 2023-10-10 | Cardiovalve Ltd. | Prosthetic valve with leaflet connectors |
US10856975B2 (en) | 2016-08-10 | 2020-12-08 | Cardiovalve Ltd. | Prosthetic valve with concentric frames |
DE102017106792A1 (en) | 2017-03-29 | 2018-10-04 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin | Heart valve prosthesis |
USD841812S1 (en) | 2017-08-03 | 2019-02-26 | Cardiovalve Ltd. | Prosthetic heart valve element |
USD841813S1 (en) | 2017-08-03 | 2019-02-26 | Cardiovalve Ltd. | Prosthetic heart valve element |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US11571298B2 (en) | 2017-08-03 | 2023-02-07 | Cardiovalve Ltd. | Prosthetic valve with appendages |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US11065122B2 (en) | 2017-10-19 | 2021-07-20 | Cardiovalve Ltd. | Techniques for use with prosthetic valve leaflets |
US11648122B2 (en) | 2017-10-19 | 2023-05-16 | Cardiovalve Ltd. | Techniques for use with prosthetic valve leaflets |
US11382746B2 (en) | 2017-12-13 | 2022-07-12 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
US11872131B2 (en) | 2017-12-13 | 2024-01-16 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
US11872124B2 (en) | 2018-01-10 | 2024-01-16 | Cardiovalve Ltd. | Temperature-control during crimping of an implant |
US11633277B2 (en) | 2018-01-10 | 2023-04-25 | Cardiovalve Ltd. | Temperature-control during crimping of an implant |
US11491011B2 (en) | 2018-09-17 | 2022-11-08 | Cardiovalve Ltd. | Leaflet-grouping system |
US11883293B2 (en) | 2018-09-17 | 2024-01-30 | Cardiovalve Ltd. | Leaflet-grouping system |
US11026792B2 (en) | 2018-09-17 | 2021-06-08 | Cardiovalve Ltd. | Leaflet-grouping system |
Also Published As
Publication number | Publication date |
---|---|
US8628571B1 (en) | 2014-01-14 |
US10500040B2 (en) | 2019-12-10 |
US20160213473A1 (en) | 2016-07-28 |
US9498332B2 (en) | 2016-11-22 |
US20180344455A1 (en) | 2018-12-06 |
US20170065407A1 (en) | 2017-03-09 |
US10045845B2 (en) | 2018-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10500040B2 (en) | Percutaneously-deliverable dual-frame valve | |
US20210137675A1 (en) | Sealing member for prosthetic heart valve | |
US11051937B2 (en) | Prosthetic heart valve | |
US11850148B2 (en) | Sealing member for prosthetic heart valve | |
CN108135592B (en) | Spacer for securing a transcatheter valve to a bioprosthetic cardiac structure | |
EP2720641B1 (en) | Prosthetic heart valve with multi-layer stent | |
EP3487452A1 (en) | Replacement heart valve prosthesis | |
WO2014105760A1 (en) | Post-implant expandable surgical heart valve configurations | |
WO2009045338A1 (en) | Collapsible-expandable prosthetic heart valves with structures for clamping native tissue | |
CA2966443A1 (en) | Prosthetic valve for replacing mitral valve | |
US20210259831A1 (en) | Support structure for an implantable device with enhanced compressive stiffness region(s) | |
US20230200980A1 (en) | Prosthetic valve with enhanced sealing | |
CN112261919A (en) | Mechanically expandable heart valve with leaflet clip | |
US20230111680A1 (en) | Prosthetic implants for displacing leaflets | |
US20220168097A1 (en) | Sealing member for prosthetic heart valve | |
WO2023146703A1 (en) | Flexible heart valve with arm attachment to outside structure | |
CN116600746A (en) | Skirt reinforcement member for prosthetic valve device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13854927 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14442541 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13854927 Country of ref document: EP Kind code of ref document: A1 |